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-ABSTRACT 
Abstract of the dissertation entitled ''Isolation of a Cationic 
Blood Protein with lns.ul in-like Activity" submitted by Harald L. 
Guenther in partial fulfillment of the requ\rements for the degree 
of Doctor of Philosophy, F~bruary, 1974. 
This dissertation is concerned with the goal of re-investigating 
the validity regarding the conflicting reports that substances other 
than insulin itself which exhibit insulin-like activity are found in 
human plasma. The principal objective was to determine whether 
insulin, when it circulates in blood, does so as cationic protein-
insulin complex. Since the finding of Antoniades and coworkers in 
1958, in which they reported on the isolation of a protein-bound 
insulin, could not be reproduced, a new experimental procedure 
was worked out to isolate this compound. 
Human serum or plasma were obtained from the Clinical Chemical 
Laboratories of the Foster G. McGaw Hospital of Loyola University 
of Chicago. Since blood was collected from numerous patients, the 
product derived from it represented a good cross-section of human 
serum. 
Pre-determined amounts of serum were mixed with a definite 
portion of Sephadex C-50, Amberl ite IRC 50 and BioRad Rex 63. High 
pH and/or high concentration of salts were avoided as required 
when attempting the elution of cationic proteins from Dowex 50 but 
iv 
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not with the much weaker exchange resins used in this project. An 
ammonium carbonate. gradient ranging in concentration from 0.005 M 
to 1.0 M was used at pH 7.8. The elution protein peaks were assayed 
for insulin activity with the rat diaphragm assay using heparin 
and biotin as possible activators in concentrations of O. lmg/ml and 
O.Olmg/ml respectively. Concentrations of 200 .!. 55, 175 .!. 70 and 
117 .!. 30 insulin equivalents/ml of plasma were calculated from 
Sephadex, Amberl ite and BioRad respectively, in ·the case of heparin 
and values of 310 .!.. 65, 298 .!.. 47 and 217 .!. 67 in the ·case of biotin. 
lmmunoreactable insulin (LRL) was detected with the radioimmuno-
assay as fo I lows~ 115 .!. 20 uU/m r, in the case of Sephadex, 107 + 
30 uU/ml for Amberlite and 89· .!.. 17 uU/ml serum in the case of 
BioRad 63 when heparin was used. Biotin did not promote the release 
of any appreciable amount of LKL. When the insulin-protein fraction 
was assayed in increasing amounts, a definite slope with the Randle 
and ~ales plot, was achieved showing that an equilibrium exists 
between the 11free11 and 11bound11 forms of insulin. Further purification 
of the insulin-protein complex (LPC} resulted in two'fractions with 
. approximate molecular weights of 158,ooo and 100,000. The latter 
compound exhibited activity in the radioimmunoassay, whereas the other 
with the higher molec~lar weight did not. With the in vitr6 diaphragm 
assay as weH,,,as with the~ vivo intraperitoneal bioassay both 
fractions showed insulin-like activity indicating that the compound 
with the higher molecular weight falls in the category of compounds 
v 
j 
isolated by Froesch and coworker~. 
Experiments i.n which tolbutamide was used to activate the IPC 
did not result in insulin activity despite earlier reports in the 
literature to the contrary. 
Since lysozyme, a strong basic protein, is eluted from the 
cationic exchange resin with the fraction containing the IPC, tests 
were performed which showed that it did not represent the basic 
protein to which insulJn might be bound. Finally, comparative 
studies to isolate lPC from different species such as from plasma 
of dogs,'horses, calves and chickens showed that the insulin-protein 
complex may well be unique to hunrans. 
vi 
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CHAPTER 1 
INTRODUCTION 
Since the discovery of insulin by Banting and Best in 1921, 
there has been a steadily growing interest in the hormone. This 
interest has not only resulted from the attention of practicing 
clinicians but has been shared by endocrinologists, physiologists, 
biochemists, protein chemists and synthetic organic chemists as 
well. Our knowledge concerning the metabolism of insulin and its 
effects on the fates of the major nutrients in the body has ad-
vanced rapidly in the l~st two decades. Parallel with the gain 
of this knowledge have been increasing attempts to elucidate the 
mechanism of insulin action. As various aspects of our under-
standing of the hormone came to fore so did innumerable ques~ions' 
associated with this knowledge. The fi.rst understanding of the 
chemistry of insulin was given to us with the brilliant achievement 
of Sanger Cl} in elucidating the complete amino acid sequence of 
insulin. However, 25 years passed before Hodgkin (2) with the aid 
of X-ray crystallography proposed a model of the three-dimensional 
structure of insulin. Before the three-dimensional structure was 
known, Katsoyannes and coworkers (3) and Zahn 1 s group (4) had 
synthesized the hormone J.!2. vitro. 
One hundred years ago, Langerhans saw the islets of the pancreas 
2 
for the first time composed of cells which we know secrete insulin. 
For a long time these cells were highly mysterious, however, today 
they are among the cells most widely studied. Methods have been 
devised to perfuse and isolate these cells, facilitating the study 
of their metabolism, insulin biosynthesis and mechanisms of insulin 
secretion. The intermediate steps can now be visualized from 
electromicroscopic pictures, on the one hand, and from biochemical 
studies, on the other. It is now possible to correlate the structure 
and function and to trace, almost step by step, the enzymatic 
·machinery of the cell to the final product, insulin, as it leaves 
the cell membrane. Proinsul in, a precursor of the hormone, has 
been discovered and many aspects of its conversion to insulin have 
been pub I ished. The physiological and non-physiological stimuli 
for insulin or proinsul in secretion and their regulation are known 
and their breakdown is being studied. An impressive amount of data 
have been accumulated and the study of insulin has served as a 
model and forerunner for research on many other hormones and proteins. 
The study of insulin deficiency, diabetes, has given rise to two 
divergent opinions as to the metabolic effects of insulin. One school 
of thought maintains that insulin deficiency decreases glucose 
oxidation, while the other maintains that it causes a increase in 
gluconeogenesis. Two tissues, muscle and liver have always been 
referred to as insulin effective. The last decade has, however, 
witnessed a great concentration of research on a third tissue, 
3 
adipose tissue, which has proved to be in the majority of anima,ls 
a most important target of insulin action. It has now become 
obvious that insulin i~ not only a regulator of carbohydrate 
metabolism but is a general anabolic hormone and has an effect on 
lipid and protein metabolism as profound as it has on carbohydrate 
metabo 1 ism. 
Until recently it has been thought that glucose was the only 
metabolite capable of stimulating both insulin synthesis and secre-
tion at physiological concentration. However, during the past five 
or six years evidence has accumulated that indicates that insulin 
secretion is affected by a diverse group o~ nutrients. Certain 
amino acids (28}, ketone bodies (29}, short chain fatty acids (30), 
medium length fatty acids (31), as.well as long chain fatty acids (32) 
have all been shown capable of provoking insulin release in different 
species under a variety of experimental conditions~ These findings 
demonstrate that in different species unique insulin response mech-
anisms have evol~ed for those substances which constitute the major 
energy supply to which the species has adapted. 
The Biosynthesis of lnsul in. 
While it is st i 11 a matter of controversy or rather of ·persona 1 
taste whether to call insulin a polypeptide or a protein it has been 
established beyond a doubt, that the biosynthesis of insulin follows 
the biosynthetic patterns of proteins and not of peptides. Certain 
\ 
peptides, as Kleinkauf et al. in 1969 (5) showed, are synthesized 
4 
directly on a multi-enzyme complex with the built-in information for 
the correct amino acid sequence, whereas proteins are synthesized 
through the well known interaction of messenger RNA, ribosomes, and 
transfer RNA's carr~ing specifi~ amino acids. That insulin is 
synthesized on the ribosomes of the beta cells was shown by Lazarow 
and collaborators (6), Lindall et al. in 1963 (?), Lazarow et al. 
in 1964 (6), and Bauer et al. in 1968 (8), in the isolated islets 
of the goosef ish. 
Taylor and Parry, in 1963 (9), and Humbel in 1965 (10), showed 
that the biosynthesis is inhibited by puromycin and later Steiner 
et al. in 1967 (11). with cycloheximide proved and pointed out that 
the site of insulin synthesis is the ribosome. 
Since it was established by Sanger (1). that insulin consists 
of two polypeptide chains, a shorter A chainwithan intrachain disul-
fide bridge and a longer B chain, the two being interconnected by 
two interchain disulfide bridges, investigators have asked them-
. selves whether or not insulin is assembled in the same manner as 
chymotrypsin. The conversion of' chymotrypsinogen to chymotrypsin 
·is the result of breakage of several peptide bonds to yield a three 
chain molecule, the intrachain disulfide bridges of chymotrypsinogen 
being thus converted to interchain bridges. The assumption was 
that the assembly of the two insulin chains followed the pattern of 
assembly of the three chymotrypsin chains, i.e. that there exists 
a single chain precursor, an insulinogen. Wang and Carpenter in 
1965 (12.) attempted' to demonstrate an insulin precursor but were 
5 
unsuccessful. Givol et al. in 1965 (13), however, obtained evidence 
indicating the existence of a single insulin precursor. They in-
cubated insulin with qn enzyme preparation from 1 iver, disulfide 
interchange enzyme, which is able to speed up the formation of the 
correct disulfide bridges in ribonuclea~e. Once the correct di-
sulfide bridges are made, the reaction stops because the molecule 
is at its favored lowest energy level and becomes thereby resistant 
against further enzyme attacks. Givol used this enzyme on insulin 
and hypothesized that if excreted insulin would be at its thermo-
dynamically lowest level it should not be acted upon by the enzyme • 
. 
His data, however, demonstrated that the disulfide bridges in in-
sulin were split and 11wrong 11 disulfide bonds were made. His con-
clusion was that insulin is not in its favored thermodynamic state 
and that therefore the assembly of two separate synthesized chains 
J.!!. vivo is unlikely. Humbel and Chrestfield, in 1965 (14), and 
Neuman et al., in· 1969 (15} confirmed Givol 1 s hypothesis. T,he 
final proof for a single chain precursor or, as it is called now, 
llproinsul in 11 , came from the work of Steiner and collaborators. 
Steiner and Oyer in 1967 (16) found in human islets• cells adenoma 
and later in normal rat islet tissue, a protein fraction which 
could be interpreted as an insulin precursor by the following criteria: 
a. Cross-reactivity with guin~a pig antiserum agai~st insulin, 
but no biological activity. 
b. Procedures which are known to split insulin into its two constit-
uents chains, do not release the separate insulin chains, but 
( 
6 
minimal quantities of trypsin do. 
c. The fraction is eluted earlier than insulin from a Sephadex 
column but after trypsin treatment the elution volume becomes 
identical to that of insulin. 
~. Incubation of islet tis~ue with labeled amino acids for short 
time periods labeled fraction b (as Steiner called it) pre-
ferentially, and chasing with unlabeled amino acids, trans-
ferred the radioactivity to the insulin fraction. 
Steiner and Oyer (16) concluded that their fraction b protein was 
the precursor of insulin - a single polypeptide chain beginning 
at the N-terminal with the B chain sequence of insulin, terminat-
ing with the A chain sequence at the C-terminal. 
Proinsulin.has subsequently been demonstrated also in bovine 
pancreas by Yip and Lin in 1967 (18), Steiner 1967 (17), Schmidt 
and Arens in 1968· (20), and in porcine pancreas by Chance et al. 
in 1968 (161} and finally proinsulin was demonstrated in codfish 
by Grant and Reid in 1968 (21}. The converting enzyme(s) which 
convert proinsulin is (are) as yet unknown. Clark et al. in 
1969 (22} suggested that most of the newly synthesized proinsulin 
is normally secreted after its conversion to insulin. Yip and 
Logothetopoulos in 1969 (23) found proinsulin in calf serum and 
Rubenstein et al. in 1968 (24), demonstrated it in human serum 
and in urine. It is important to point out (Shaw and Chance (25)) 
that. even though proinsulin crossreacts with guinea pig antiserum, 
it fails to show any biological activity. 
7 
Regulation of lnsul in Biosynthesis. 
Bauer and Lazarow in 1961 (8), and Humbel and Renold in 1963 
(26), were unable to demonstrate a significant stimulatory effect 
of high glucose concentrations on insulin biosynthesis in isolated 
.. 
fresh islets .!.!J. vitro. However, Smith et al. in 1964 (27), re-
ported that raising the glucose concentration from 25 to 250 mg per 
cent increased biosynthesis in bovine pancreas slices by a factor 
of ten. Parry and Taylor in 1966 (9), extended their observation 
and found that mannose also stimulated insulin synthesis whereas 
galactose had no effect and mannoheptulose proved to be a very 
potent inhibitor of insulin biosynthesis. During the last few 
years a number of compounds besides glucose have been shown to 
influence the release of insulin. Amino acids (28), ketone bodies 
(29), short- (30}, medium- (311 and long chain fatty acids (32} 
have been shown to stimulate the release of insulin. 
Glucose and mannoheptulose both seem to act on the synthesis 
and release. Hormones, such as ACTH and glucagon, stimulate in-
sulin release but do not have any effect on its biosynthesis. 
Taylor and Parry in 1967 (33), and Grey and coworkers in 1970 
(34}, demonstrated the presence of an inducible gluco-receptor in 
the rat islet cells which seems to be responsible for induction of 
insulin biosynthesis by glucose. 
lnsulin Action. 
The effects of insulin can be understood most clearly when one 
first considers and enumerates the metabolic abnormalities seen in 
8 
the pancreatectomized animal or in the most severe form of human 
diabetes. In insulin deficiency, the blood glucose level is ex-
traordinarily high. The glucosuria, polyuria and mineral losses 
, . 
are a direct consequence of the high blood sugar level. In muscle 
and 1 iver, glycogen is practic~lly depleted. The synthesis of 
proteins is sharply decreased and amino acids are rapidly trans-
formed to sugar, ketone bodies and urea. All metabolic deviations 
can be restored to normal if insulin is made available. The search 
for a direct effect of insulin upon one or'another of the key 
enzymatic reactions is still subject to controversy and debate. 
The direct effects on some of these enzymes will be discussed a 
u 
little later in .this chapter. 
On the basis of work l!:!_ vivo and in vitro using non-metabolized 
sugars, it was shown that insulin ha~ a profound effect on the rate 
of membrane transport of sugars (35, 36). Tjis was shown to be 
true in particular for glucose in a variety of tissues, namely 
skeletal and cardiac muscles, fat cells and fibroblasts (37-41). 
The molecular mechanism of sugar transport is still poorly 
understood, but it seems reasonable to assume that one is dealing 
with a specific carrier molecule in the membrane and that insulin 
undoubtedly accelerates the activity of this carrier system (42, 43). 
The uptake of glucose mediated by insulin, by its target tissues, 
follows in sequential steps: first, transcapillary passage of the 
sugar to the surface of the cell; second, membrane transpassage 
into the cell, and third, intracellular conversion of the sugar to 
9 
one of its metabolites. The first step, the passage of glucose 
from the capi l lari·es to the cel 1 is not rate 1 imiting; it occurs by 
rapid diffusion and i~ not accelerated by insulin as shown by Morgan 
et al. in 1961 (44). The second, or transport step, which has been 
studied by Morgan et al. (45) and Park et al. (37) is very much in-
sulin dependent. The third step is the only rate limiting step; 
here, the sugar is trapped by the cell. Morgan (44) showed that 
the shuttle of glucose into the cell is reversible, even though in-
sulin dependent, but the conversion of glucose to glucose-6-phos-
phate, which is independent of insulin, determines the amount of 
glucose which is transported into the cell. The transport of a 
sugar across the cell membrane seems to be selective, D-glucose 
will be transported whereas L-glucose will not (43). How the 
transport proceeds is still a mystery, mainly because we do not, 
a~ yet, understand in detail the exact molecular composition and 
arrangement of the eel l membrane. The view most consonant w.ith its 
various functions is that the cell membrane consists of an external 
and. internal protein layer, between which is sandwiched a bimolecular 
leaflet of ordered lipids, mostly of the phosphol ipid variety. The 
protein layers seem most probably to consist of a precisely arrayed 
assembly of catalytic materials, enzymes, coenzymes and modu.lators 
of their activity. It is, therefore, reasonable to assume that 
insulin combines in a unique way with a specific molecule in the 
membrane, and that such binding with the receptor disturbs the 
special arrangement of the membrane in such a manner that the sugar 
10 
carrier can now operate at full capacity. 
Effect of Insulin on Metab~lism. 
The abnorma 1 it i,es in metabo 1 ism due to i nsu 1 in deficiency in 
the whole organism are the sum of the contributions of all its in-
dividual tissues. The effect and action of insulin have been 
studied and investigated almost exclusively on organisms which 
suffer diabetes mell itus or which have been made diabetic with 
drugs such as alloxan or streptozotocin (160). As already men-
tioned elsewhere, insulin acts directly on adipose tissue, muscle 
and on liver. Instead of considering each individual tissue to 
discuss its action, an attempt will be made to review the knowledge 
as it has been elucidated in carbohydrate metabolism in the liver. 
It is widely assumed that insulin controls to a great extent the 
metabolic. machinery at the level of enzyme induction (40-57). 
( / 
Since in liver, no permeability barri1er for glucose seems to 
be present, the assumption has been made that insulin exerts its 
influence on the metabolism of the hepatic cell chiefly by con-
trolling the amount and activity of enzymes present. In 1 iver, as 
in other organs, glycolysis and gluconeogenesis oppose each other 
and this is reflected in the opposing functions of key glycolytic 
and gluconeogenic enzymes. The identification of the regulatory 
significance of the four key gluconeogenic enzymes (glucose-6-phos-
phatase, fructose-1, 6-diphosphatase, phosphoenol-pyruvate kinase 
and pyruvate c.arboxylase) and of the three glycolytic key enzymes 
(glucokinase~ phosphofructokinase and pyruvate kinase) is based on 
'• 
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ti'\eoretical grounds and on experimental studies of the behavior 
of these enzymes under physiological and pathological conditions 
(46-57}. When enzyme assays are carried out at optimum saturation, 
levels of substrates, cofactors, coenzymes and under 1 inear kinetic 
conditions, then the specific activities measured represent the 
amount of the corresponding enzymes present. Since these specific 
proteins, enzymes, are considered the final expression of gene 
activity, it can be assumed that the amount of enzyme present is 
an indicator of gene expression. It has been observed by Weber and 
coworkers (Li6-54), that insulin in plasma induces key glycolytic 
enzymes and, at the same time, suppresses the gluconeogenic enzymes. 
The tv:o enzymes that Weber traced were g 1 ucose-6-phosphatase and 
pyruvate kinase. When rats v1ere starved for long periods of time 
or rnc:de diabetic the opposite effect v1as observed. Upon refeedirig 
of test animals, insulin induced a rise in the key glycolytic 
enzymes vvhich >vas blocked by inhibitors of protein synthesis such 
as actinomycin, puromycin and ethionine. 
Do5e response studies demonstrated that the insulin-induced 
rise in the activity of glucokinase, phosphofructo kinasa and pyru-
vate kinase was dose dependent (51). These results, however, may 
have been due to factors such as the nutritional state and not in-
suJ in levels in plasma. More direct proof of insulin being an 
enzyme inducer was obtained by Weber et al. by injecting anti-in-
sul in serum into the rats before refeeding the animals. This in-
sured that no biologically active insulin was circulating in the 
plasma. Their results shovJed no increase in the glycolytic enzyme 
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level, whereas in rats that received no anti-insulin, an increase 
of 3 to 400 per cent in enzyme levels above the starving levels was 
observed. 
The integratio~:of 1 iver carbohydrate metabolism by insulin, 
acting by controlling enzyme synthesis is a powerful and effective 
metabolic control. However, since protein synthesis and· degradation 
requires a number of hours, and sometimes days, for effectiveness, 
this mechanism can not account for the rapid hepatic response to 
insulin. The acute action of insulin which may be manifested in 
a few minutes probably then does not involve increase in enzyme 
activity through modulation of gene expression. In the acute control 
it has been shown that cyclic 3,5 1 -AMP plays a strategic role(139). 
I • 
~ 
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The State of lnsul in in Plasma. 
The methods used for the measurement and evaluation of insulin 
in plasma wi 11 be described in the chapter 11Assays for Blood lnsul in. 11 
(p.21). 
The various assays used to determine insulin in blood often 
give rather divergent results (Table I). In some of the methods, 
different physical treatments of the plasma apparently caused a· 
considerable rise in insulin activity, thus raising the question as 
to whether activity of plasma insulin might not be due to a con-
version from one form to another ~epending on circumstances both 
in vitro or in vivo. 
TABLE I 
lnsul in or Insulin-Like Activity in Pooled Rat Sera 
by Different Bio-Assays. 
lnsul in or insulin-] ike Actiiity* 
Experimenta 1 
condition 
.fed 
Fasted for 3 days 
Alloxan diabetic 
Rat diaphragm 
intraperitoneal 
420 
76 
31 
Adipose tissue 
in vitro 
479 
250 
104 
*Values expressed in microunits per mg of crystalline insulih 
equivalent. 
Immune 
assay 
53 
18 
l l 
14 
TABLE I I 
lnsul in or Insulin-Like Activity in Plasma Samples 
·From Normal Human Subjects. 
lnsul in or insul in-1 ike activity'~ 
Subject 
A 
B 
c 
D 
Ra.t diaphragm 
intraperitoneal 
86 
100 
81 
102 
Adipose tissue 
in vitro 
36 
265 
330 
710 
*V~lues expressed in microunits per mg of crystalline insulin 
equivalent. 
lmmuno 
assay 
5.9 
11. 8 
2.0 
19.5 
Table I From Partamin, Raisa and Cahill: Metab. Cl in. Exptl., .!2_: 
10, 1966. 
Table I I From Cahill et al.: Metab. Cl in. Exptl., .!l= 769, 1964. 
These data seem to indicate that insulin may be transported in 
plasma partially as free molecules and partially in another form, 
perhaps bound in some way to certain plasma proteins. The pos-
sibility that insulin is bound or transported by a carrier protein, 
as it is the case with thyroxin has stimulated a large number of 
studies on the subject. Currently the 1 iterature is very confusing 
on this subject; thus various investigators use phrases such as 
11Bound insul in 11 , ''lnsul in-1 ike activity", 11 repressible and non-
repressible11 as well as "atypical insulin" to descr.ibe insulin which 
is not active under physiological conditions and which may be bound 
to some car~ier molecule. 
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Bound lnsul in. 
Studies on 11 bound 11 i nsu 1 in using the rat diaphragm assay have 
come almost exclusively from the laboratory of Antoniades and co-
workers. In 1958, Antoniades (58) showed that insul in-1 ike activity 
(ILA) could be eluted from a cationic excnange resin, Dowex 50 or 
IRC 50, which prior to elution, was mixed with whole blood. The 
elution of the ILA was. achieved by using 0.02 N ammonium hydroxide 
(61). Since crystalline insulin is not adsorbed by the resin, it 
was hypothesized that the acidic insulin molecule is bound to a 
basic protein which itself is adsorbed to the cationic exchange 
resin. Antoniades and coworkers (59) studied ILA by using acid 
ethanol precipitations of plasma. To prevent coagulation of the 
blood, two methods wer.e employed. The blood was either treated 
with acid cit.rate dextros.e (ACD), or passed through a cationic 
' 
exchange resin to decalcify the samples, and thus 'inhibit coagulation. 
The samples preserved by the treatment with ACD retained all the in-
sulin-like activity, whereas the samples treated with the cationic 
·.exchange resins lost almost all acti~ity as measured by the rat 
adipose tissue bioassay. Antoniades then eluted the resin with 
0.02 M NH40H, because he thought that the ILA may have been bound 
to the resin. The resin eluate showed no insulin activity when 
assayed using the rat diaphragm bioassay: however, the resin eluate 
showed marked insulin activity when the rat adipose tissue bioassay 
was used. These investigators (60) then prepared a saline extract 
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of rat epididymal fat pads and combined it v-lith the resin eluates 
(bound insulin) and tested .the mixture with the diaphragm assay; 
the resin eluates plus the fat pad extracts showed insulin-like 
activity, indicating that the fat pads contained a factor capable 
of activating inactive insulin. In vivo studies by Antoniades 
et al., in 1969 (61), have indicated that adipose tissue extracts 
(ATE) produce hypoglycemic activity in insulin-sensitive animals 
using intravenous or intraperitoneal administrations of partially 
purified adipose tissue extracts from rat or bovine fat tissue. 
Preliminary studies by Antoniades (60) on the nature of the 
possible active factor have shown that it is heat stable and has a 
molecular weight below 1,000 (60). Gundersen and Antoniades in 
1960 (62) found that when the resin eluate was dissolved in a 
buffer solution of pH 9,8 the resin complex could be dissociated. 
Furthermore, they sho1ded that, at pH 9,8, the basic protein pre-
cipitated and 11free'' insulin could be detected !n the supernatant 
after centrifugation. Dialysis, without prior neutralization of 
the insulin-protein complex as eluted from the resin column at 
pH 10.2, against saline for 24 hours, markedly reduced the insulin-
like activity in contrast to dialysis of the cc~plex which had 
previously been neutralized. This was interpreted by Antoniades 
as an indication that the insulin-protein complex may recombine 
slowly at neutral pH. The studies, conducted by Antoniades et 
al. (63-65), which seemed to show that insulin exists in two forms, 
a 11free 11 and a "bound" form, and that the equilibrium is shifted 
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toward the 11free 11 form upon ingestion of a glucose load, were 
criticized by a number of investigators. Antoniades further 
postulated that, in some cases of diabetes, one of the main 
problems may well be the inability to convert the complex or 
11 bound 11 insulin to the 11free11 form, leading, therefore, to the 
observed deficiency in total insulin activity. The electro-
phoretic mobility of bound insulin corresponds to that of the 
beta and gamma globulins (66, 67). The molecular weight of the 
insulin-basic protein complex is approximately 60,000 accordoing 
to its behavior on Sephadex G-75 ~nd G-100 (68). Antoniades (69) 
reported.that bound insulin is not neutralized by insulin anti-
serum, whereas Shaw and Shuy (70) were able to neutralize bound 
insulin when they repeated Antoniades• work. Berson and Yalow 
(71, 72) were, however, unable to demonstrate an increase in 
plasma insulin using the/ radioimmunoassay. The findings of Berson 
and '(alow were confirmed by Kipnis et al. (73} and Mead et al. (74). 
furthermore, an extensive study by Mead (.75) has failed to confirm 
.an effect of adipose tissue extract on the effect of ILA in the 
diaphragm assay. Berson and Yalow (76) dismissed Antoniades 1 work 
by stating that he had fallen victim to an artifact of the ex-
perimental procedure. They state: "Bound insulin has no con-
vincing ~asis and in fact is a phantasy that has i~sidiously 
captured the fancy of several investigators 11 • Berson and coworkers 
defend their statement by their failure to demonstrate insulin-
like activity with the radioimmunoassay and by their failure to 
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combine exogenous 1251-insulin, when injected into experimental 
animals, to the proposed basic protein carrier. 
II lnsulin-Like·Activity (tLA). 
The observation of M.artin et al.. in 1958 015) and Renold et 
al. 1960 (118) that adipose tissue .!J:_'vitro is remarkably sensi· 
tive to small amounts of insulin, and therefore suited for the de-
termination of insulin in biologic fluids, opened up a vast and 
much disputed field of insulin-like acti~ity (ILA) in human serum. 
The many difficulties started when it became apparent that anti-
insul in serum suppressed only a ~ertain amount of the insulin-like 
activity of serum, meaning that one is de~ling with a compound 
which behaves like human insulin yet does not crossreact with in-
sulin antiserum. The serum ILA which was not inhibited by insulin 
antibodies was termed 11non-suppressible11 (NSILA) or 11atypical ILA11 
(77). The fraction of lLA which can be eluted from a cationic ex-
change resin was called 11suppressible11 or 11 typical 11 ILA. Serum 
insulin which is not adsorbed by the resin is named 11free 11 insulin 
(78}. The introduction of the radioimmuno-assay by Berson and 
Yalow in 1966 (72) gave investigators a tool to compare the values 
of serum lLA obtained with bioassays with those obtained with 
immunological techniques. 
The measurements of non-suppressible insul in-1 ike activity 
(NSILA} are performed with the in vitro diaphragm (158) or adipose 
tissue as~ay.(115). It should be noted thai the values for serum· 
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NSILA,. obtained by the diaphragm technique were reported to be 
lower than those measured by the adipose tissue assay (79-81). 
The expl~nation for.this phenomenon wil.l be described in the 
discussion of the adipose tissue bioassay. The diaphragm just 
does not respond equally well to all the compounds of serum 
NSILA that are measured by the adipose tissue technique. Froesch 
et al. (82) demonstrated through paper electrophoresis and gel 
chromatography on Sephadex G-200 that NSILA of native serum 
~epresents a large molecule with an approximate MW of 150,000, with 
electrophoretic properties of an ~lpha2 or beta-golbulin (83, 84). 
Fractionation of serum by zone electrophoresis separated adqed 
1251-insulin in the alpha 1-globulin-albumin region from NSILA 
which has an electrophoretic mobil·ity of a beta- and gamma-
globulin (85). NSlLA was found also in the albumin-alpha-globulins 
a·s well as in the gamma-globulins by several autho.rs working with 
electrophoretic techniques (81, 86, 87). The isoelectric point 
of purified NSILA (88) 1 ies betwee.n pH 6.0 and 8.0, \n contrast to 
. insulin which has an isoelectric point at pH 4.0. Modification of 
the isolation method for NSILA by several investigators resulted 
in many disagreements with respect to recovery and suppressibility 
of the extracted NSILA by insulin-antibodies and its persist.ence 
after pancreatectomy (84, 86, 89, 90}. Buergi et al. (82) ex-
tracted NSILA with acid-ethanol from a Cohn fraction of human 
plasma containing mostly alpha- and beta-globul
1
ins, and estimated 
the molecular weight of the biologically active material to be 
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6,000 to 10,000 by gel filtration on Sephadex G-75. When an 
acetone powder of human plasma, which contained 80% of the total 
human serum NSILA, was extracted by Jakob et al. (89), they 
found a NSILA compound with a molecular weight of 45,000. 
In a study on the properties of NSILA, Froesch et al. (94) 
showed that it had the same effect as did crysta11 ine insulin on 
the net gas exchange when measured with the adipose tissue assay. 
Incorporation of 14c-g1ucose into fatty acids and its oxidation to 
14co 2 by NSILA is comparable to that by insulin in equivalent 
amounts. However, incorporation of radioactive glucose into 
glycogen was not stimulated as much by NSILA as by insulin (90). 
Buxtorf, in 1969 (91}, studied the influence of NSILA on protein 
synthesis. His investigations revealed that even though NSILA 
appears to act on membrane transport, lipogenesis and 1 ipolysis, 
it did not affect protein synthesis in the same way as does 
insulin. 
lt is interesting to note that the level of NSILA seems to be 
the same in normal patients as in patients with disorders of carbo-
hydrate metabolism. Diabetic subjects, patients in diabetic coma 
and patients with beta-islet cell adenoma have similar NSILA le-
vels (941. Variations of blood sugar, induced .by insulin and glu-
cose in human subjects (92) or by fructose (93) and mannoheptu-
lose (94) do not influence the level of NSILA; Power (95) sug-
gested that non-suppressible ILA may be a third pancreatic hor~ 
'~ 
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mone. However, his statement has not been proven, and, in fact, 
the origin of NSILA is not known as yet. 
All the information which has been. obtained indicates that 
NSILA cannot replace insulin as a unique hormone controlling the 
metabolic machinery. The hypothesis that NSILA might play a role 
in inflammation, during work or other situations in which local 
enhancement of glucose uptake might be necessary is a reasonable 
one; however, no clear proof has yet been obtained ( 163). 
Assays of lnsul in in Blood. 
Reviewing the di.fferent methods for the assay of insulin in 
blood, Goetz (36) has written: 
"So much controversy has arisen from studies employing 
current methods for.insulin assay in blood that a fresh 
consideration of these methods at this time may have some 
value, although the subject has been repeatedly reviewed 
by others~" 
Perusal of the current literature reveals that a major part pf 
what is being written deals with methods of insulin assay, the 
results obtained, and the controversies generated by them.· 
For example, Yalow and Berson (97) write: 
11 1t is sufficient to note here that the radioimmuno-
assay, properly performed, measures only insulin and no~ 
other plasma substances that may exhibit insulin-like ac~ 
tivity in biological systems." 
On the other hand, Williams and Wood (98) state: 
11The biological assays measure the net effect of many 
factors, positive and negative, influencing glucose uptake. 
Certain advantages would seem to be derived from the in-
clusion of plasma factors influencing the insulin action 
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since some of the patients• tissues are similarly affected. 11 
The two statements reflect differences in desire as to what is 
to be measured by t~ese assays. 
Methods in vivo. 
1. Hypoglycemic Tests. 
Since the accepted criterion of insulin action is a fall in 
blood sugar, the first insulin assay methods made use of this fact. 
An examp 1 e of such a method is that of B,e i ge lman (99), who measured 
blood sugar decrem~nt in mice. The sensitivity of this method was 
1000 microunits. Beigelman concluded that this method is neither· 
sufficiently sensitive nor sufficiently reproducible to constitute 
an effective insulin assay. Average normal fasting values for 
human plasma insulin are about 15-20 microunits per ml, as deter-
mined by immunoassay (loo}. l.t is thus obvious that a method in 
vivo such as the one described is unsuitable. 
These J.!l vivo methods can be made more sensitive, however, by 
adrenalectomizing and/or hypophysectomizing the test animal. These 
, procedures are also designed to abolish the effect of hormonal 
·antagonists of insulin. If one makes the animal diabetic with 
alloxan, one jncreases the sensitivity of the assay even further. 
This sort of assay was described by Bornstein (101). With a rat 
which was hypophysectomized, adrenalectomized and made alloxan-
diabetic the sensitivity of the test method is to 50-500 microunits 
of insulin. The preparation of such altered test animals is 
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difficult, time consuming and expensive and their. mortality is 'high. 
2. The in vivo lntraperitoneal Bioassay. 
Rafaelsen (102, 103) found that when small quantities of 
insulin, less than 10 milliunits per animal, are injected intra-
peritoneally, the effects of the hormone are limited to the tissues 
immediately surrounding the peritoneal cavity. In particular the 
diaphragm as well as the epididymal fat pads are affected by the 
presence of insulin. In the case of the fat pads, valuable results 
can be obtained only if the testis of the test animals are pushed 
into the abdominal c~vity, and the communication between peritoneal 
and scrotal spaces is closed. This preparation is necessary in 
order to insure intraperitoneal location of the epididymal adipose 
tissue for good contact with the substances injected. The muscle 
(~iaphragm} and the adipose tissue \fat pads) are very sensitive 
to insulin, for glycogen formation in the diaphragm and incr.eased 
lipid synthesis in the adipose tissue. This assay is open to a 
number of questions. Is the assay sensitive enough to.measure 
physiological concentrations of insulin? Does insulin attach itself 
to other muscles such as heart and trapezius muscle or to subscapular 
brown or possibly mesenteric fat? In 1965, Rafaelsen and coworkers 
(104) answered these questions. They showed that neither in brown 
I 
or mesenteric fat, nor in the heart or trapezius muscle, could any 
lncorporation of radioactive glucose l4c(U) be detected. As it 
regards sensitivity, as low as 10 microunits, the use of radioactive 
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tracers such as glucose 14c (U) made the assay suitable for small 
amounts of insulin. Young, 1967 (105), and Young and coworkers, 
1969 (106), used th~~ assay to detect changes of insulin effective-
ness on muscle tissue when insulin was injected together with sera 
or tissue extracts. They reported that .tissue extracts did not show 
any appreciable decrease which might have been attributed to mole-
cules binding insulin. 
The intraperitoneal method to test insulin~~ thus has the 
\ 
following advantages; first, it involves the diaphragm, an intact 
working muscle; second, serum can be tested with the dilution 
usually required for insulin tests~ vitro; third, it permits the 
simultaneous measurement of insulin effects on both muscle and 
adipose tissue if needed; and fourth, since the effect of insulin 
appears to be only a local one, there is probably little involvement 
of factors secreted in response to a systemic disturbance of meta-
bolic homoeostasis. The test, however, also has a drawback, in 
common with other bioassay procedures conducted~~' in that 
it may become. very imprecise unless optimal conditions, such as 
weight of the animals, change of environment, etc., are carefully 
controlled. 
l 
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The in vitro Insulin Bioassays. 
l. Rat and Mouse Diaphragm Assay. 
Bioassays ~vitro employ either whole diaphragm or more 
commonly hemi-diaphragm and even quarter diaphragms of mouse or 
rat. In short, the assay is performed as follows: the tissue is 
incubated in physiological buffer solution, such as Krebs-Ringer 
(107) or Gey-Gey (108) containing glucose in a water saturated 
atmosphere of 5% carbon dioxide in oxygen. The insulin-sensitive 
event on which the assay depends is either glucose uptake or 
r 
glycogen synthesis. The glucose uptake, which is.measured according 
to Krahl and Park (109), has been abandoned almost completely due 
to its insensitivity. Berson and Yalow (110) have shown that in 
the range of 10 to 100 microunits of insulin per ml, the insulin 
concentration·must be increased by about 225 per cent to produce 
a 1% glucose concentration. The formation of glycogen, irdu~ed 
and augmented by insulin, is the method by which insulin is measured 
cur(ently. Glucose in the incubation medium is spik~d wlth a known 
·amount of glucose 1-14c which will b~ incorporated into the glycogen. 
The amount of radioactivity appearing in the glycogen will then be 
taken as a parameter for the amount of ·insul.in present in t~e medium: 
This test shows a sensitivity of 10 to 500 microunits of insulin as 
shown by Moody and Feller (111) in a comparative study of insulin-
sensitive parameters in the mouse diaphragm. Moody and Feller 
found that insulin sensitivity increases in the following order: 
glucose uptake, total radioactivity of.tissue incubated with 
! 
f 
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glucose 14c, chemical determination of glycogen formation and 
formation of glycogen from labeled glucose. The disadvantage of 
the diaphragm bioass~y is that substances which might be found in 
plasma may interfere. Goetz (112) has listed some, namely, 
epinephrine (96), free fatty acids and apparently the B chain 
of insulin itself (113). As 1 ittle as 0.01 microgram of epi-
nephrine, almost completely counteracts the effect of 500 micro-
units of insulin on rat diaphragm. In addition to these inter-
fering substances, appreciable degradation of insulin occurs 
especially when cut preparations (hemi- or quarter diaphragms) are 
used (114). ,Proteolytic enzymes are leached out of the cut 
muscle fibers into the medium where they then may hydrolyze the 
insulin. 
2. The Adipose Tissue Bioassay. 
This bioassay was first introduced in 1958 by Martin and 
Renold (115}. The biochemical principle is that adipose tissue 
responds to insulin with an increase in glucose uptake with a 
preferential oxidation of the sugar via the hexose-monophosphate 
shunt. The reaction pathway is: 
1-14c-Glucose 1- 14c-Glucose-6-phosphate---+ 1- 14c-
phosphogluconic acid 
1-14c-phosphogluconic acid + NADP_____. 14co2 + NADPH + 
ribulose-5-P. 
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The insulin sensi~ive parameters that can be measured are glucose 
uptake as measured by Beigelman et al. (116), total gas exchange 
reported by Ball et.al. (117), or formation of 14co2 from 
14c-glucose 
as worked out by Renold et al. (70). As shown by Martin (115) and 
Renold (118), the fat pad bioassay exhibits great sensitivity to 
insulin, up to 10 microunits. However, a very disturbing feature 
in interpreting the results obtained from the use of this assay is 
the question of specificity. It was first shown by Leonards (119) 
that insulin-like activity of normal human serum, as determined 
with the fat pad, exhibits a very different behavior from that of 
insulin. Unlike insulin, the activity is not extractable by acid 
ethanol and is not .neutralized by insulin anti-serum. What is 
even more striking, the activity exists after total pancreatectomy 
in the dog. The nature of the insulin-like factor present in 
serum, as d_escribed in the introduction, is a factor isolated and 
somewhat identified by Froesch and coworkers (120). It is well 
known and established that the fat pad responds to a 'great. many 
·substances. A list of such insulinomimetic agents was published 
by Ball and Yungas (121). A list of biologically active peptides 
with insulin-like effects can be found in a review by Minsky (122). 
Due to reasons mentioned here it seems obvious that-the fat pad 
/ 
l 
bioassay in spite of its v~ry high sensttivity and lack of specificity, 
is limited in its use. 
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The Radioimmune Assay for Insulin. 
Unlike the bioassays discussed in the foregoing section, 
.. 
which depend on some metabolic response of tissues in vivo or 
~vitro, the radioimmunoassay, developed by Berson and Yalow 
(123-125), is based on a chemical reaction in the test tube 
between a hormonal antigen and its antibody and exploits the well-
known specificity of immunochemical reactions. This method has 
introduced much needed specificity in the assay of plasma insulin 
an~, for that matter, for other hormones in plasma as well. The 
sensitivity of this method is very high, as little as 2 micro-
units of insulin per milliliter can be detected (126). Various 
modifications of the original method are in current use (127, 128). 
All assays employ competition between 13 11 or 1251-labeled in-
sulin and the unlabeled insulin in the unknown sample for binding 
sites on the anti-insulin globulin. To make an analytical assay 
. which can be performed with I ittle effort, the insulin antibody 
complex has to be made insoluble. It is well known that insulin 
is a very poor antibody producer. Among mammals, guinea pigs do 
produce rather good insulin antibody tit.ers. Since insulin anti-
bodies are monovalent~ the antibody-antigen complex will remain 
in solution. It is therefore necessary to develop the ''double 
antibody" method (128, 129) in which the antibody-bound hormone 
is precipitated with a second antiserum directed against the 
immunoglobulir.is of the anti-hormone serum (thus, for anti-insulin 
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serum developed in guinea pigs, an antiserum to guinea pig 
globulin is required for the precipitation stage). The antiserum 
to guinea pig globulins is p~oduced in rabbits. Interference 
by complement in the second antibody reaction has been avoided 
by the inclusion of chelating agents such as EDTA (130, 131). 
The antibody-bound labeled insulin is identified by procedures 
which separate free from bound. insulin, and the amount of unla-
beled insulin is determined by comparison with a standard curve 
which relates the 11 ratio of antibody-bound to free insulin 11 to 
11 known hormone con cent rat i on 11 • T.he greater the quantity of 
unlabeled insulin to be assayed, the smaller will be the quantity 
of labeled insulin bound to antibody, assuming that the antibody 
has the same affinity for both insulins, labeled and unlabeled. 
This assumption has been questioned by Arquilla, Ooms and Fen (157). 
They·found that the attachment of 1251 to insulin seems to impair 
the immunological as well as the biological activity of the hormone. 
The immunoassay method offers a great number of advantages 
.over the bioassays. It is not only the high degree of specificity 
which makes it so attractive but also the small amount of test 
substance required for the test; furthermore it doe~ not suffer 
from complications of interfering substances in plasma. It is 
therefore not surprising that the radioimmunoassay has replaced 
the bioassays almost completely. It has found great acceptance 
in clinical laboratories where it has been automated (132, 133). 
Results obtained by the radioimmunoassay. fat pad and diaphragm 
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bioassays frequently have been compared. Goetz (96) made a 
critical appraisal of the comparisons in which he says: 
11Comparison between assay results by different methods 
obtained in different laboratories, or even in the same 
laboratory must be accepted with reservation because of 
the lack of precision which has been accepted as the price 
of great sensitivity of •these methods 11 • 
They note that there is apparently very 1 ittle relationship 
among the absolute values of insulin in plasma samples assayed 
by different methods. 
CHAPTER 11 
MATERIALS AND METHODS 
Radio immunoassay of lnsul in 
The radio.immunoassay was carried out using a modification (146) 
of the procedure described by Hales and Randle (127). This assay is 
sufficiently sensitive to satisfy research requirements and is well 
suited to the prob 1 em of hand 1 i ng. 1 a rge numbers of samp 1 es. 
Reagents: 
1. Insulin binding reagent (double antibody} used in all immuno-
assays is prepared by the Wellcome Research Laboratories, Beckenham 
K~nt, England.BR3 3 BS and distribut,ed by Amersham/Searle Corpora-
tion, Arlington Heights, Illinois. The batch which we used was 
labeled as #l<.4908 and had the Catalog number MR48. 
The.commercial product is prepared in the following manner! 
Antisera are prepared to insulin (in guinea pig) and to guinea pi~ 
serum proteins (in rabbits). After adjusting t.he titer of an 
anti-insulin serum, it is diluted in phosphate buffer containing 
EDTA (ethylenediamine tetra-acetic acid) and mixed with a pre-
determined amount of the anti-guinea pig precipitating serum. 
The mixture is allowed to react at 4°C for 18 hou~s and tnen free~e-
31 
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dried. When reconstituted to a volume of 8 ml each vial will 
contain precipitated guinea pig serum, diluted 1:16,000 in buffer B 
(see buffer preparat_ion) containing _0.03 M EDTA. This reagent 
then will bind approximately 40 per cent of a standard dose of 
250 picograms of insulin. 
2. Radio-iodinated Insulin. 
1251-insulin was obtained from Amersham/Searle C., Batch #6 
Catalog number lM38. The 1251-insulin is prepared from specially 
purified crystalline ox insulin with a potency.of 24.3 inter-
national units per milligram; unbound iodine is removed by gel 
filtration. Each vial contains O.l microgram of 1251-insulin 
dissolved in buffer A (see buffer preparation). 
3. Buffer Solutions. 
Buffer A - 40 mM phosphate buffer, pH 7.4, for dilution of anti-
sera and iodinated insulin. 
7.0 g 
1.0 g 
sodium phosphate monobasic - monohydrate 
(NaH2P04 • H20) 
sodium az i de (NaN3) 
1.0 g polyvinylpyrrolidone (PVP), Matheson-Coleman and 
Bell, ~orwood, Ohio. 
Sodium hydroxide, 2 N, to adjust to pH 7.4 
Deionized water to 1 liter, pH adjusted to 7.4 
Stored at 4°C. 
-----·--- ·---·· -- --- ----- -- ·------------------·--···--·· -· -- ----,--- - --------
l 
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Buffer B - Buffer for dilution of standard insulin and plasma 
samples. 
9.0 g sodium chloride (NaCl) 
Buffer A, to 1 i ter 
Stored at 4°C. 
Buffer C - Buffer for washing antibodies. 
39.0 g PVP 
Buffer A to 1 1 iter 
Stored at 4°C. 
Composition of Scintillation Fluors. 
Fluor 150 'ml ethanol (absolute) 
300' ~1 p-dioxane (scint111ation grade) 
50.g naphthalene (recrystallized) 
5 g 2~5-diphenyloxazole (PPO) Packard, lot #4627 
Toluene (scintillation grade, Beckman} to 1 i ter 
Fluor ll 50 g naphthalene 
5 g PPO 
p-dioxane, to 1 liter 
Fluor lll 5 g PPO 
Toluene, to liter 
) 
All fluors were stored in brown bottles, away from direct light. 
Of the three fluors, No. I I l was used exclusively, since the 
counting effi'ciency was the same as that obtained with the more complex 
fluors I and.) I. 
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Apparatus. 
a) Micropipettes. 
Microliter pipettes, Eppendorf or Oxford, were used (size 
10 µ 1, 50 µ l and 100 µ l). These pipettes were obtained from 
Scientific Products, Chicago, Illinois. 
b} Filtration apparatus. 
The filtration of the insulin antibody complex was performed 
with the Millipore manifold. (Sampling Manifold #3025, Catalog 
#XX 27 02530 Millipore Company, Bedford, Massachusetts). 
c} · Fl l ters. 
Due to their uniformity, Gelman filter discs were used rather 
than the commonly used Millipore filters. (Gelman Instrument 
Company, Ann Arbor, Michigan). 
d) Test tubes. 
Micro-test tubes (5 x 50 mm) Kimax, available from Scientific 
Products, proved to be very suitable for the experiments. 
e) Liquid scintillation. 
The radioactivity of the insulin antibody complex was measured 
with a Beckman Liquid Scintillation Spectrometer, Model LS-250. 
Assay Procedure. · 
Volumes of 0.1 ml of insulin binding reagent were dispensed 
I 
into 5 x 50 mm culture tubes, which were kept cold in an ice bath. 
The binding reagent which comes in powdered form was re·constituted 
L 
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as follows: to 1 vial of powdered reagent, 8 ml of deionized 
water was added carefully and mixed gently to avoid foaming. 
Aliquots of 0.1 ml of the unlabeled insulin standards (see 
preparation of insulin standards), unknown solutions, or blanks 
consisting of buffer B were added to the culture tubes containing 
the binding reagent. The tubes were then mixed In a Vortex Jr. 
Mixer and placed in the refrigerator for 6 hours at 4°C. 
After 6 hours, the tubes were removed from the refrigerator 
·and returned to the ice bath and O. 1 ml of the prepared 1251-iodi-
nated insulin solution was added to the tubes. This working solu-
tion was prepared in the following manner: 1.0 ml of the commer-
cially available radioactive insulin (Amersham/Searle) was with-
drawn from the ampule with a syringe and carefully added to 7.0 ml 
of buffer B. After the working solution of 1251-insulin was made 
the mixture was mixed and then returned to the refrigerator for 
18 hours. The final composition of a representative series of 
tubes is given in Table IV. At the end of 18 hours, the tubes 
were removed from the refrigerator and placed in ·the ice bath for 
processing. A micro-analysis filtration apparatus was used to 
collect the precipitated insulin antibody complax. Prior to the 
start of the assay, the membrane filter discs (Gelman) were pre-
soaked in cold buffer C for at least 24 hours. The filter discs 
were then applied to the filter holders using forceps and the 
apparatus was connected to a vacuum of approximately 14mm Hg. 
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With the aid of Pasteur pipettes, the contents of the culture 
tubes were carefully applied to the filter discs. Each filter 
was then washed twic·e with 1.0 ml of cold buffer C. The purpose 
of these washings was to remove unbound radioactive insulin. 
The filters were then removed from the manifold with forceps and 
placed immediately into appropriate counting vials. After all 
the samples had been processed in this manner, the counting vials 
were placed for 15 minutes in a drying oven preheated to ll0°C. 
Once the scintillation vials were cooled to room temperature 
10.0 ml of scintillation fluor lll was added. The filter discs 
have to be absolutely dry before the fluor can be added. The 
filters will become transparent once the fluor is added; if 
moisture remains in the filter material, they will not become 
transpacent and the measure.ment of the radioactivity will be 
impaired. 
The samples were then placed in a Beckman LS-250 liquid 
scintillation counter and allowed to dark-adapt for 2 hours. In 
all cases_, the vials were counted for 10 minutes, in three cycles. 
The third count, in almost all instances was used for the data 
evaluation. 
The gain control was set at 360 and the full window isoset 
was employed to obtain maximum efficiency in the counting. The 
external standard ratio system of the instrument was employed to 
1 .. 
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monitor the relative quenching of the samples and to determine 
whether or not corrections for quenching would have to be applied 
to the results. The external standard ratio (ESR) reading reflects 
the efficiency of the count for each individual sample. If there 
is a considerable variation in ,the external standard ratios of 
the individual samples, then a correction factor must be appl led 
to the raw results of the counts to compensate for a varying 
efficiency in counting of different samples. If the ESR readings, 
however, .are uniform, then this reflects the fact that the efficiency 
of the counts is uniform enough to make any correction factor un-
necessary. It was found that the samples were very uniform with 
~espect to the external standard, thus no quenching correction was 
necessary. One set of replicates was prepared to obtain a control 
count. These tubes were the wash control samples; only iodinated 
irisutin and buffer were placed in th~ culture tube~ They reflected 
the degree of retention of the free labeled insulin by the filter 
discs. 
Preparation of lnsul in Standards. 
Preparation of First Stock Solution (200 µg/ml) 
10.0 mg of lnsulin (Sigma, Bovine pancreas insulin recrys-
tallized, product #15500, assay 23,4 internatio~al units) 
was weighed out and placed into a small beaker (10.0 ml) 
and dissolved with 2 - 3 ml of 0.03 M HCl. This solution 
was transferred quantitatively to a 50 ml volumetric flask 
) . 
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and deionized water was added up to the mark. Aliquots of 
0.1 ml were dispensed in small vials and stored at -20°C. 
These preparat1ons were found to be stable for several 
months. 
11 Preparation of Second. Stock Solution (2 µ g/ml) 
2 ml of buffer B (see buffer preparation) was added to one 
of the vials containing 0.1 ml of the first stock solution. 
After careful mixing, the solution was transferred quantl-
tat ively to a 10 ml volumetric flask. The flask was filled 
to the mark with buffer B. This solution was prepared 
fresh for every assay and kept at 4°C until used. 
111 Initial Working Standard (20 ng/ml) 
0.5 ml of the second solution was placed in a 50 ml volu-
motr ic flask and diluted to the mark with buffer B. From 
this solution a series of standard solutions were prepared 
according to the following table~ 
l. 
Standard 
Number 
2 
3 
4 
5 
6 
Initial Working 
Standard 
0.2 
0.2 
0.2 
1.0 
1.0 
1.0 
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TABLE 111 
WORKING STANDARDS 
Buffer B Final Insulin Concentration 
ml Concentration ng/ml uU/ml 
9.8 o.4 10 
4.8 0.8 ' 20 
1.8 2.0 50 
4.0 4.0 100 
1.5 8.o 200 
20.0 500 
The radioimmuno assay was run in 5 duplicates since the sensitivity 
up to 5 micro units of the test creates rather high deviations among 
samples having the same i.nsulin concentration. 
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TABLE· IV 
FINAL COMPOSITION OF SAMPLE TUBES IN RADIOIMMUNOASSAY OF INSULIN 
.. 
. ,.,, .... 
Tube # I nsu Jin I nsu Jin Buffer 1251- Buffer Insulin Concen-
Binding Standard ~ Insulin A µl/ml tration 
Reagent ng/ml 
(0. 1 ml) (0. 1 ml) (0. l ml) (0. 1 ml) (0. 1 ml) 
l - 5 + Std. + 10 0.4 
" 
·5 - 10 + Std. 2 + 20 0.8 
10 - 15 + Std. 3 + 50 2.0 
15 - 20 + Std. 4 + 100 4.0 
~o - 25 + Std. 5 + 200 8.0 
~5 - 30 + Std. 6 + 500 20.0 
:o - 35 + + + 0 0 
:5 - 40 + ++ 0 0 
0 - 45 ++ + 0 0 
Tube #30-45 represents the control. 
I~ 
-· 
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. Data Evaluation. 
If one plots the increasing concentration of insulin· (abscissa) 
vs. the counts (ordinate) one will obtain a kind of exponential curve. 
However, if the concentrations of insulin vs. the counts are plotted on 
a semi-logarithmic scale, an approximate straight line is obtained. 
The author, however, preferred to plot all his results and evaluate 
them with the so-called 11Hales and Randle Plot 11 (127). In principle, 
the plot was worked out in the following manner: if a given volume 
of a solution of 125 1-labeled insulin, of c~ncentrations 2i and 
0 
specific activity~ is mixed with ao equal volume of buffer or a 
solution of unlabeled insulin of concentration 2i, then the concentration 
of 125 1-labeled insulin w!ll be i
0 
in each case, but the specific activi-
ty will be reduccid in the presence of unlabeled insulin to xi /(i +i). 
0 0 
It follows that the change in specific activity will be a function of 
i and that the latter may be estimated by reference to a known standard 
solution of insulin, if the changes in specific activity can be measured. 
The theoretical relationship for the principle of isotope dilution 
as applied to the immunoassay is as fo~lows: 
Let C be the radioactivity of the insulin-antibody complex when 
0 
is zero. 
Let C. be the radioactivity of the insulin-antibody co~plex when the 
I 
concentration of unlabeled insulin is i . 
. 125 Let l + I be the amount of I-labeled insulin bound by antibody, 
0 
then under these conditions, 
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I I = i 0 0 + i/i 0 + l 
and c = x I and c. = x 0 0 I 
and c I c. = I I I 0 I 0 
then c I c. = i l/i + 0 I 0 
It fol lows that c I c. will be linearly related to i ' that C I c. 0 I 0 I 
wf ll be unity when i is zero, that i is minus 
- -0 
when C I C. is zero 
0 I 
and that the slope of the line is 1/i . 
0 
The theoretical relationship holds only if one assumes that the 
affinity of the antibody for 125 1-labeled insulin and unlabeled in-
sulin is the same. 
The Rat Hemi-diaphragm Assay. 
As stated in the chapter 11Assays of .Insulin in.Blood" the hemi-
diaphragm method was employed in order to measure insulin as well as 
insulin-like activity. The radioimmunoassay measures only free 
immunologically active insulin. 
Procedure. 
a. Animals and tissue 
The animals use~ were male albino rats supplied by Holtzman, 
Madison, Wi~consin. The rats were fed ad libitum with Purina 
Laboratory Chow. The rats at the time of use weighed between 
120 and 140 gm. Twenty four hours prior to the experiments 
the rats were kept in separate cages and fasted. The diaphragm 
was dis sec t·ed and used. 
l 
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Incubation flasks. 
The flasks used.for the incubation were Erlenmeyer flasks 
holding 10 ml. They wer: stoppered with sleeve-type stoppers 
and small plastic cups with a plastic holder were pushed through 
the stopper. 
Incubation Media. 
The buffer solution used for the incubation was prepared according 
to the protocol out 1 i ned ·by Gey and Gey ( l 08). 
) 
Constituents 
NaCl 
KCl 
NaHC03 
CaC 1·2 (.anhydrous) 
MgC1 2 ' 6 H20 
Na 2HP04 2 H20 
KHlo4 
MgS04 ' 7 H20 
TABLE V 
Concen-
tration 
g/l 
7.00 
0.37 
2.27 
o. 17 
0. 21 !' 
o. 15 
0.03 
0.07 
Stock Solution 
Mo 1. cone. g/l 
5.0 292.20 
1.0 74,55 
J.O 84.01 
0.1 1]. 1 
J.O 203.33 
0.5 89.03 
J.O 136. l 4 
0. 1 24.65 
Quantities 
for B.S.S. 
ml per liter 
24.0 
5.0 
27.0 
15.3 
1.0 
1. 6 
0.2 
3.0 
In order to achieve physiological pH, the buffer has to be equilibrated 
with a gas mixture of 95% o2 and 5% co2 . The glucose concentration 
of the mixture was 300 mg per 100 ml of buffer. 
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·Preparation of Solution containing Glucose-1- 14c. 
For each batch of tracer glucose, 50 Ci of glucose-1- 14c 
(Amersham/Searle Cai, Arlington Heights, Illinois) was diluted to 
a concentration of 0.5 Ci per 0.1 ml. 
Preparation of Insulin Standards. 
A single batch of insulin has been used for this experiment 
(fryst. insulin, Sigma Chemical Co., batch #llC-1210, 24.3 l.U. 
per mg}. A concentrated insulin standard was prepared by dissolving 
10.mg of insulin in 10 ml of deionized water. The concentrated 
standard thus contained 24.3 units per ml. This solution was stored 
at 4°C. Before running the assay one ml of this solution was brought 
up to 24.3 ml with deionized water, so that 1 ml contains 1 U. From 
this solution 1 ml was taken and diluted 1 to 100 with incubation 
buffer containing glucose. The insulin concentration was then 10 mU 
per mlj 1 ml of this dilution was further diluted l to 10 with the 
same buffer to bring the final concentration to 1,000 micro units 
per ml. From this concentration, serial dilutions were prepared to 
obtain concentrations of 1,000, 500, 250, 125, 62.5 and 31.25 uU 
per ml. 
Assay Technique~ 
Principle. 
Rat hemi-diaphragms were incubated in Gey-Gey buffer with 
glucose-1- 14c for 2 hours ~t 37°c. At the end of the incubation, the 
l 
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14c incorporation into glycogen was also determined. The amount 
of 14c incorporated into glycogen and co2 was then rel~ted to the 
insulin present in the medium. 
Procedure. 
Into each assay flask, 1.9 ml of unknown solution or standard. 
solution was pipetted. Exactly 0.1 ml of glucose-1- 14c was added 
making the total incubation solution 2 ml. The flasks were then 
weighed to the nearest mi 11 igram and kept. stoppered to prevent 
evaporation. 
After the flasks were prepared, rats were killed by a blow on 
the head followed by decapitation. The diaphragms were dissected 
as rapidly as possible and placed }n Gey-Gey buffer, and cooled in 
an ice bath until used. The diaphragms were cut into two equal 
parts and placed into the incubatio~ flasks. The flasks were then 
\ 
re-weighed to'determine the weight of the hemi-diaphragm.· After 
gassing for l minute with a gas mixture of 95% o2 and. 5% co2 using 
#21 'hypodermic needl.es inserted through the rubber stoppers, the 
needles were withdrawn and the system was left airtight. The in-
cubation flasks were then put on a metabolic shaker for 2 hours at 
37QC. Particular caution was taken to maintain the physiological 
pH of 7.35 - ].40. 
Liquid Scintillation Countin~~ 
The counting of the radioactivity of isolated glycogen of dia-
phragm, was performed in a Beckman LS-250 counter. Each sample was 
counted three times for 10 minutes each. 
r 
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Scintillation Fluid. 
The cocktail was comprised of scintillation grade toluene, 
5 g PPO per 1000 ml find of Bio-Scilve BBS-3, 20 ml plus 100 ml of 
the toluene-PPO mixture. The technique of determining the radio-
. . f 14 . l " d d" h activity o C in g ycogen,was one accor 1ng tote procedure 
pub! ished by Rafaelsen and coworkers (104). 
Isolation of Glycogen. 
After the incubation period, the pr~-weighed hemi-diaphragms 
were placed in glass centrifuge tubes (12 x 100 mm). Three ml of 
a 30% potassium hydroxide solution. were added and the contents were 
heated for 30 minutes in a waterbath at l00°C. After hydrolysis, 
the glycogen was precipitated by the addition of 0.2 ml of 2,5% 
sodium sulphate and 1.6 ml absolute ethanol for each 0.5 ml hydroly-
sate. After keeping the samples for 18 hours at -15°c, the samples 
were centrif.uged in a precooled (-15°C) International Refrigerated 
·Centrifuge for 20 minutes. The supernatant was carefully decanted 
and discarded. After decantation and draining, the precipitates 
were washed twice with 2.0 ml of cold 66% ethanol (v/v) and centrifuged. 
The precipitates were then dissolved in exactly 1.0 ml deionized water 
and aliquots were taken and placed in liquid scintillation vials. The 
results were plotted on linear graph paper, (counts per minute per 
gram of tissue vs. the concentration of insulin standard or unknown). 
The curve which resulted from the insulin standard was a straight line. 
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The ln Vivo lntraperitoneal Assay for lnsul in. 
The intraperiton~al .!.!2. vivo bioassay was performed, basically, 
according to the technique outlined by Rafael sen and coworkers (104) 
with some minor modifications, as described by Young and coworkers 
034[. 
Animals. 
The animals used were the same as described in the hemi-diaphragm 
assay (p9ge 42}, except that their weight' was between 90 - 120 grams. 
Materials. 
Radioactive glucose (D-glucose- 14c (U} with a specific activity 
of 2..9 mCi/rnM or 16. 1 µCi-mg glucose was used in al 1 experiments. 
14 The D-glucose- C (U) was obtained from Amersham/Searle, Arlington 
Heights, Illinois. The insulin used for preparing the standards 
was bovine insulin, from pancreas, 24.6 IU (Sigma Biochemica)s), 
The bovine albumin was replaced by PVP polyvinylpyrrol idone from 
Matheson-Coleman and Bell, Norwood, Ohio. 
·procedure. 
The small male rats, faster for 24 hours, were injected. intra-
peritoneal ly with 1.5 ml of the test solution.' 
The test solution was composed of: 
al 2 µCi D-glucose- 14c (U) 
b) 1 mg D-glucose 
c} 5% PVP (w/v} 
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d) the whole mixture was dissolved in physiological saline 
e) insulin in various concentrations as well as unknown tast 
. . 
substances~-
The injections were made on the right side, midway down the 
abdomen. Once the injection of fluid starts, the needle must not 
be moved, otherwise 1 it is impossible to say whether or not some 
of the fluid may go into the intestine rather than into the cavity. 
Lt is recommended that the needle be inserted at an approximate 
angle of 25°. Leakage through the puncture can be prevented by 
releasing the rat 1 s leg when the injection is completed and waiting 
for a further 5 seconds before withdrawing the needle. After in-
jection, the animals were individually returned to their respective 
cages. An important detail ·of the procedure, which has been kept 
nearly constant throughout, is the time interval in which the 
animals were injected and sacrificed. Each rat should be killed 
. 2 hours after injection. 
The .rats were sacrificed by a blow on the head and subsequent 
decapitation. The diaphragms were removed as follows: the xiphoid 
cartilage was grasped with forceps, at a right angle to the rat, 
and twisted half a turn so as to depress the ribcage and expose 
the diaphragm. The diaphragm was then punctured with sharp forceps 
or with a scalpel, in the central non-muscular area between the. 
inferior vena cava and the xiphoid process. This releases the 
negative pressure in the chest and causes the diaphragm to billow 
L 
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out. The diaphragm was grasped with forceps at the plqce of puncturing 
and the right and lef~ hemi-diaphragms were dissected. Without 
releasing the grip on the tissue, the severance was completed by 
cutting around the margin of the ribcage. The dissected tissue was 
washed in saline, dried and immediately frozen with dry ice. After 
freezing the tissue, it was weighed and placed in glass centrifuge 
tubes and hydrolyzed with 30% KOH. The isolation and counting of 
the glycogen was performed in the same manner as in the previously 
described rat hemi-diaphragm bioassay. 
Rat.:. Adipose Tissue'Bioassax. 
The third and last bioassay which was employed ,to determine 
insulin-like activity was the rat-adipose tissue bioassay. As al-
ready pointed out in "Assays of lnsul in in blood 11 (page 21), this 
assay exhibits the highest sensitivi'ty of all the bioassays. How-
ever, it also is the least specific in so far as it responds to 
insulin-like activity from compounds other than insul,in. 
·Procedure. 
This bioassay was performed basically in the same manner as 
the rat hemi-diaphragm bioassay. 
Animals and Tissues. 
See rat hemi-diaphragm assay. 
· lncubation Flasks. 
The flasks used for the incubation were the' same as described 
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in the hemi-diaphragm assay (Corning Culture Flasks). 
Incubation Media. 
The buffer solution for the incubation of the adipose tissues 
was Gey-Gey buffer. Its preparation and composition is given on 
page 43. The preparation of the glucose-1- 14c containing solution 
as well as the preparation of the insulin standards are identical 
to those described and used with the rat hemi-diaphragm assay 
(page 44}. 
Principle of the Assay~ 
Rat adipose tissue is incubated in Gey-Gey buffer with 
glucose-1- 14c for 2. h_ours. At the end of the incubation, the total 
co2 present in the system is liberated by the addition of acid 
added to the medium and is trapped in ~mall -amounts of NaOH which 
is in the trap. The sodium carbonate so obtained is transferred 
in exact aliquots into a scintillation vial and its radioactivity 
determined. - The total radioactivity of the co2 is expected to be 
directly proportional to the amount of the first carbon of glucose 
oxidized to co2 and, as will be shown later, is further related to 
the amount of insulin present in the system. When the radioactivity 
per gram of adipose tissue is plotted against insulin concentration, 
the shape of the plot took the form of a sigmoid curve. If one 
plots the logarithm of the counts (ordinate), then a straight line 
r 
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up to 500 uU of in~ulin can be obtained, making a standard curve 
which is very suitable for the evaluation of the unknow~s. 
Isolation of the Insulin-Protein Complex (IPC)~ 
Materials. 
Human serum was obtained from.the clinical chemistry laboratory 
of the Foster G. McGaw Hospital of Loyola University of Chicago. 
The serum was collected from numerous patients, pooled and immedi-
ately frozen. The final pool should thus. represent a good cross-
section of sera. Frozen human plasma from healthy persons was ob-
tained through the courtesy of the Hematology Department of Pres-
byterian-St. Luke 1 s Hospital, Chicago, Illinois. The cationic 
exchange resin used was Sephadex C•50, Amberlite IRC-50 (Fisher 
Chemicals}, BioRad Rex 63 (BioRad Laboratories), and Dowex 50 
(Baker Chemical Corporation). For the gel filtration, Sephadex 
G-200.was used. All Sephadex products were purchased from Pharmacia 
Fine Chemicals Inc., Pescataway, New Jersey. Except for those 
.studies which compared the effectiveness of the resins for the 
isolation of the IPC, Sephadex C-50 was used to isolate the in-
sulin-protein complex. 
Isolation Method Using Sephadex C-50. 
ln each case, 500 ml of pooled human serum was stirred for 
3 hours at 4°C with 10 g of Sephadex C-50 resin. The Sephadex 
resin was allowed to hydrate overnight prior to use. The mixture 
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was then filtered on a Buchner funnel. The recovered resin was 
" subjected to repeated washings with 2 - 3 liters of cold deionized 
.;' I 
water. The washings were performed with the Sephadex resin on the 
Buchner funnel. A column m~asuring 2.5 x 100 cm (columns were 
obtained from the Pharmacia Company) was then packed with the pre-
washed resin. To remove further anionic and neutral proteins, a 
0.005 M aqueous solution of ammonium carbonate was run through the 
column until a steady baseline was reached on a UV monitor. The 
collection of the fractions and the monitoring of the protein 
content was done with a full automatic fraction collector unit 
(LKB Produkter A B, Sweden; UV Control unit Type 8300, Recorder 
Type 6520-3, Ultraviolet Detector Type 8303 A and Fraction Collector 
Type 7000). The entire unit was kept .Jn a coldroom in which a 
constant temperature of 4°C, was maintained. A salt gradient of 
ammonium carbonate from 0.005 M to 1.0 M, was applied to the column 
at pH 7.8. The flow rate of the column was adjusted to 0.5 ml per 
minute with the aid of a peristaltic pump (LKB). Each elution peak 
which appeared with increasing salt concentration was pooled and 
the pH was adjusted to 7.3 .:.. 0.1 with acetic acid. Following the 
pH adjustment; the pooled peaks were desalted and concentrated with 
an Ultrafiltration apparatus (Ami con Corp., Lexington, Massachusetts), 
using a UM 10 membrane which permits passage of all substances below 
a molecular weight of 10,000. 
L 
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The concentrated elution peaks were freeze-dried. All peaks 
were then tested for insulin-like activity with the rat hemi-
diaphragm bioassay. Before performing the bioassay, the protein 
fractions were dissolved to attain a predetermined protein con-
centration in Gey-Gey buffer pH 7.4 and dialysed for approximately 
8 hours against the same buffer with various changes during this 
period of time. 
Isolation of IPC with Other Cation Exchange Resins. 
The commercially available resins were first v1ashed \vith de-
ionized water until fine particles were removed and the super-
natant was colorless. A specified amount of each individual resin 
v/as treated \-Jith 3 times its volume of 3M HCl and stirred for 
about 20 minutes. The HCI was then decanted and the resin ~ashed 
until neutral with deionized water. An alkaline treatment with 
1 U ~~aOH vias followed to convert the resin into its sodiun forn. The 
amount of NaOH to achieve conversion to the sodium form was aporox-
imately three times the volume of the resin. This material was then 
washed once more until neutral vdth normal saline· {0.15 M NaCl). 
The i4a+-resins were then stirred with pooled human serum, 5 tir:ies 
the amount of the resin, for 5 hours in the cold room at 4°C. 1he 
resin was then allowed to settle and the serum was decanted, 
frozen and stored for determination of insulin-like activity which 
was not absorbed. The recovered resin was packed in a column and 
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saline was used to elute all physically absorbed proteins. Once 
a steady baseline on the UV monitor was reached, a potassium 
chloride gradient, 0':15 M to 3M KCl, was employed. The elution 
peaks were dialysed and concentrated with an Amicon Ultrafiltrator. 
To obtain proper physiological buffer concentrations (Gey-Gey) for 
the hemi-diaphragm bioassay, BioRad Cellulose fiber dialysis was 
used L 163). 
Gel Filtration Chromatography. 
Gel filtration was carried out exclusively with Sephadex 
products, G-75, G-150, and G-200. The Sephadex powder in all 
instances \iJas allowed to hydrate according to the specifications 
outlined by the Pharmacia Company. Columns were packed with the 
desired hydrated Sephadex and subsequ~ntly. equilibrated with 
various buffers. The elution peaks were recorded with LKB UV 
monitor at 280 nm. The flow rate was regulated with the aid of 
a LKB peristaltic pump. 
Procedure for the Determination of Lysozyme. 
The lytic activity of lysozyrne was measured quantitatively by 
the radial diffusion-gel technique described by Schumacher and 
Wied (136) and Osserman and Lawler (137) using agar.gel containing 
suspended dried 11Micrococcus lysodeikticus 11 cell walls. 1% Nobel 
Agar (Difeo Laboratories, Detroit, Michigan) solution was prepared 
in S¢renson buffer, pH 7.0 (138} and 30 mg Micrococcus lysodeikticus 
were added to 100 ml dissolved agar which had been cooled to 50°C. 
( 
r 
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The liquid ag~r was then applied to a LKB immuno-diffusio~ set 
(LKB Instruments, Rockville, Marylahd). Micrococcus ly~odeikticus 
were obtained from \forthington Biochemical Corp., Freehold, New 
Jersey. Standaras, as well as samples, with unknown. lysozyme con-
centrations were placed into wells cut in the agar with a LKB well-
cutter. The enzyme diffused radially and lysed the Micrococcus agar 
forming transparent discs around the well. The diameters of these 
discs depended on the concentration of the enzyme. The substance in 
the wells were allowed to diffuse in an incubator at 37°C for 6 
hours. Chicken.egg white lysozyme (E.C 3.2.l.7 muramidase, salt 
free twice crystallized, Worthington Biochemical Co.) was used as 
a standard. The st.andards were prepared in the same salt concentra-
tion as those of the unknowns to a;sure equal diffusion rates. The 
results of the method were plotted on a semilogarithm paper (radius 
' 
of lysis (abscissa) vs. lysozyme concentration (ordinate), log scale). 
Determination of the Molecular Weight of Insulin-Protein Complex 
With the Gel Filtration Method. 
For this purpose, a Sephadex G-200 column (100 x 2.5 cm) was 
prepared and equil tbrated with a 0.05 M Tris - -0.l M NaCl buffer 
pH 7.4. The void volume was determined with Blue Dextran, MW about 
2.,000,000. Proteins with known molecular weights were run individually 
on the column • 
.. 
a Aldolase 
b Ovalbumin 
c Chymotrypsinogen A 
cl Ribonuclease A 
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10 mg 
10 mg 
10 mg 
10 mg 
MW 158,000 
MW 45,000 
MW 25,000 
MW 13,700 · 
The enzymes 1;1ere supplied by Worthington Biochemical Co. and 
distributed in a kit by Pharmacia Fine Chemicals, Inc. Each pro-
tein resulted in a single symmetrical peak. The number of test 
tubes (5 ml/tube), counting the tubes from the start to the midpoint 
"of the peak, were plotted on semi-log paper (MW log scale on the 
ordinate and tube number, volume, on the abscissa), obtaining a 
straight 1 ine. The elution peak of the insulin-protein complex 
was then compared to this plot and the molecular weight estimated. 
The conolex was of course run over the same column under the same 
conditions. 
Preparation of Crude Adipose Tissue Extract. 
The adipose tissue extract {ATE) was prepared essentially 
according to Antoniades (60). Pooled rat epididymal fat pads from 
animals supplied by Holtzman, Madison, Wisconsin, VJeighing between 
180 and 220 grams, were homogenized in normal saline (0.15 N NaCl) 
in the coldroorn a: 4°C with a VirTis 45 homogenizer. The ratio of 
tissue to saline Has maintained at 10 g fat pads to 50 ml of saline. 
The homogenate was passed through a cheese cloth to remove fat and 
tissue debris. The filtrate was then subjected to a 30 minute 
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centrifugation in a pre~cooled Sorvall centrifuge at 15,000 g. 
The upper layer consi~ting of solid as well as liquid 1 ipids was 
carefully removed and the supernatant collected. The clear solution 
was then brought up to 60% ethanol (v/v) by adding, under constant 
stirring, 100% ethanol. The temperature of the mixture was main-
tained at 0°C in an ice-bath containing sodium nitrate. After l 
hour, the precipitate which had formed was centrifuged and discarded. 
The ethanol of the supernatant was evaporated with a rotary 
evaporator. The remaining liquid was then passed through an 
Amicon ultrafiltration apparatus using a UM 2 membrane which permits 
the passage of substances below a molecular weight of 1,000. The 
filtrate was then concentrated and desalted on a Sephadex G-10 
column (100 x 1.0 cm}. The eluant from the column was lyophil ized. 
and the powder used for assaying the insulin-protein complex with 
the hemi-diaphragm assay. Besides rat epididymal fat pad ti~sue, 
human· mesenteric fat (postmortem, kindly suppl led to us by the 
Depq.rtment of Pathology of Foster G. McGaw Hospital, 'Loyola University 
of Chicago) was used to prepare adipose tissue factors. 
/ 
CHAPTER 111 
RESULTS 
The purpose of this dissertation is to attempt to determine 
the validity regarding conflicting reports in the literature, that 
substances whlch exhibit insulin-like activity other than insulin 
itself, are present in human plasma. 
We were, in particular, interested in whether or not insulin 
circulates in plasma as an insulin-protein complex. In order to 
pursue this task, insulin assays had to be set up to measure immuno-
reactive insulin. The following insulin assays were chosen: 
a. the radio immunoassay 
b. the in vitro rat diaphragm bioassay 
-
c. the in vivo rat intraperitoneal bioassay 
--
d. the in vitro rat adipose tissue bioassay. 
The radioimmunoassay was set up according to Hales and Randle (127). 
Only one modification was introduced, namely bovine albumin which 
is required in all buffer solutions was replaced by PVP (146). 
Gre.::it emphasis ~vas placed on the choice of the filter discs 1,1hich 
have to be used to filter out the insulin-antibody complex. Studies 
by Przybyla (146) revealed that the Mi 11 ipore filters supplied by 
Searle/Amerhsam gave results v1hich were not reproducible. Gelman 
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filter discs \-Jere therefore used in all immunoassays, due to their 
excellent filter properties and reproducibility of results. 
A set of bovine insulin standards 1-1as prepared, as shovm in 
Table I I I. They ranged in concentrations from 10 to 200 µU/per ml of 
insulin. The 1-;orking solutions of labeled insulin and insulin 
binding reagent 1-;ere prepared as discussed in "Materials and Methods", 
page 39. The samples were counted for 10 minutes with Fluor I II as 
the scintillation medium. The results are listed in Table VI and 
-Figure l. All results were corrected for fluor background and wash 
controls. 
The rat diaphragm bioassay was performed according to Vallance-
Ov.;en et al (159). Minor changes were e:.iployed as far as the glu-
cose concentration of the incubation media was concerned .. Glucose 
concentrations of 300 mg/100 ml were used instead of 250 mg/100 ml, 
because the incorporation of glucose i~to the muscle tissue appeared 
to bi more pronounced. The methodology is outlined in detail on 
page 42 • As seen on Figure 2 and Table VI I, the diaphragm assay 
is not linear, when the insulin concentrations fall below 20 µU, 
Above 20 µU and up to 250 µU, the assay is linear and reproducible, 
and therefore is suitable for estimating insulin within these ranges 
of concentrations. (Above fasting values in normal persons.) 
The rat intraperitoneal bioassay 1r1as chosen to determine the 
activity of insulin and its insulin-I ike substances under more 
phystological conditions. This assay, in comparison to the other 
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TAB LE VI 
RADIO-IMMUNE ASSAY STANDARD 
# of Tests I nsu 1 in in CPM Co/Cl Co/Cl Average CPM 
µU 
+ S.E.M. + S. E. M. 
1 10 8880 1. 142 1.167 .!.. 0.019 
2 10 8864 1. 144 
3 10 8175 1 .241 
4 10 8631 1 • 17 5 
5 10 8932 1. 136 
1 20 8541 1. 188 1.193 .!.. 0.017 
2 20 8647 1. 173 
3 20 8034 1. 263 
4 20 8624 1 • 176 
5 20 87·03 1 • 166 
50 7333 1 .384 1 • 513 .!.. 0. 061 
2 50 6573 1. 544 
3 50 5847 1. 735 
4 50 6992 1 • 451 
5 50 6996 1 • 451 
1 100 5642 1. 798 
' 
1 • 951 .!.. 0.052 
2 100 5246 1 .934 
3 100 4784 2. 121 
4 100 5258 l'. 930 
5 100 5140 1.974 
1 200 3774 2.689 2.744 + 0.218 
2 200 3571 2.842 
3 200 3908 2.596 
4 200 3251 3. 121 
5 200 4104 2.473 
1 0 9922 10149 .!.. 265.6 
2 0 10306 
3 0 11065 
4 0 9929 
5 0 9526 
·· . 
. :J':• 
Figure 1.- Standard curve of the radioimmunoassay, as plotted 
according to the method of 11Hales and Randle 11 • Each point on 
the graph was obtained from five duplicates. 
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Animal I nsu I in Tissue CPM CPM/gm CPM/S.E.M. 
N=5~" µU mg Tissue 
1 50 368 10723 29138 . 28884 ! 310 
2 50 343 9892 28839 
3 50 391 11773 30111 
4 50 411 11465 27897 
5 50 317 9014 28437 
1 100 291 9242 31762 31277 !447. 
2 100 307 9508 30971 
3 100 252 8215 32600 
4 100 271 8126 29986 
5 100 311 9662 31070 
1 150 . ,381 . 13901 36485 36159 ! 749 O' 
2 150 443 15689 . 35415 N 
3 150 411 15918 38732 
4 .. 150 289 9881 3419l 
5 150 367 13203 35976 
1 250 247 10431 42230 41736 !942 
2 250 267 11107 41599 
3 250 367 16519 45011 
4 250 342 13619 39823 
5 250 298 11916 39989 
I -- 341 6856 20105 20399 ! I 083 
2 . -- 360 6948 19300 
3 -- 401 9515 23728 
l 4 -- 402 7076 17601 
5 -- 371 8500 22911 
6 -- 290 5438 18751 
--
* Five different rats have been used for every point. 
TABLE V 11 
Figure 2. - The graph represents a typical standard curve when 
crystal I ine bovine insulin is assayed with the rat hemi-diaphragm 
bioassay. The standard values on the graph represent five 
individual rats with similar body weight. The CP~ on the ordinate 
14 
x 10,000 expresses C-glucose incorporation into muscle glycogen. 
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assays, has the advantage in that high insulin concentrations, up 
to 10 mU, can be measured. However, it has disadvantages which are 
cor.imon to all other in vivo assays. Unknown factors in the intact 
animals cannot be controlled and therefore may obscJre the results; 
furthermore there exists the unpredictability of the test animal. 
The results from the.!.!: vivo bioassay, which was carried out according 
to Rafael sen and coworkers, are listed in Table VI I I and Figure 3. 
Finally, the data for the standard curve of the rat adioose tissue 
-- ____,_ __ ----
bioassays are shown in Table IX and Figure 4. As pointed out earlier 
in the 11 lntroduction 11 , the procedure outlined by Martin and Renold 
was utilized, It can be seen from the graph that this assay has 
a limitation when it comes to measuring insulin concentrations above 
500 uU. Jue to the lack of specificity, this partic~lar bioassay 
procedure was adandoned. 
Isolation of the lnsul in-Protein Complex by Cationic Exchange 
Chronatograohy. 
In the literature review of bound insulin, it was pointed out 
that workers in several laboratories tried unsuccessfully to duplicate 
AntoniaJes 1 work, namely the isolation of bound insulin. Przybyla 
(146), in this laboratory, obtained preliminary evidence that in 
human plasma there could possibly be a compound exhibiting insulin-
like activity, when Antoniades 1 methods were employed for the iso-
lation procedure. It was, therefore, decided to reinvestigate this 
problem using various isolation procedures. Antoniades 1 procedure 
as foll01.1ed by the author is outlined belmv, in brief form. 
Rats lnsul in Tissue CPM CPM/gm CPM/gm ± S.E.~\:·-
N = 5 µg mg Tissue 
1 50 269 1035 3847 3939 ± 12 
2 50 251 1008 4015 
3 50 243 951 3913 
4 50 261 1024 3925 
5 . 50 239 955 3998 
1 100 338 1361 4023 4357 ± 64 
2 100 305 1370 4493 
3 100 285 1281 4512 ' . '· 
4 100 290 1293 4459 
5 100 315 1354 4299 
1 200 332 1649 4878 4825 ± 245 
2 \ 200 304 .1375 4523 
3 200 j 310 1507 4861 
4 200 283 1407 4972 
c; 
v 
5 200 309 1481 4889 
1 500 269 1511 . 5617 5543 ± 36 
2 500 444 2438 5491 
3 500 . 370 2039 5511 
4 500 290 1583 5459 
5 500 319 1798 5637 
1 · lOOO ~; 406 4459 10982 10998 ± 68 
2 1000 400 4400 11000 
3 1000 380 4246 11173 
4 1000 298 3207 ·10762 
·5 1000 344 3218 11073 
1 -- 323 1046 3238 2778±118 
2 -- 452 1195 2643 ... 
3 -- 410 1120 2733 
i 
4 -- 402 1039 2586 
5 -- 375 1009 2691 
TAB LE V 11 
Figure 3. - This standard' curve is obtained when crystalline 
·bovine insulin is assayed J..12. vivo with the rat intraperitoneal 
bioassay technique. 
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ADIPOSE-TISSUE BIOASSAY - STANDARD CURVE ,, 
Rat Insulin Tissue CPM CPM/gm Tissue CPM/gm Tissue 
.. 
No. ·k µU . mg Average 
63 530 17424 32875 33340 
} I 63 405 13732 33906 
2 125 503 22992 45709 
' . 
43805 
... 
2• 125 509 21328 41901 
3 250 560 36384 64971 67451 
3' 250 J 653 45666 69932 -
4 500 537 73964 137735 139040 
41 500 411 57682 140345 
5 1000 812 121442 149559 148856 
5' 1000 767 113634 148153 
6 -. 439 10394 23676 24255 
6' - 455 11300 24835 
J. 
"land l' means one rat each of the epididymal fat pa_ds v;ere used in the assay. 
TABLE .IX 
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TABLE X 
,· 
ADfPOSE TISSUE BIOASSAY 
Insulin CPM/gm Tissue 
µU ± S.E.M. 
63 33760 ± 735 (3) 
125 44017 ± 917 (3). 
250 67924 ± 498 (3) 
. 500 140068 ± 916 (.3) 
1000 149853 ±1093 (3} 
23621 ±1377 (3} 
Summary of three independent runs • 
. -
Figure 4. - The graph represents a standard curve of crystalline 
bovine insulin when rat epididymal fat pads are used as the target 
tissue for insulin. The ordinate shows the CPM per gram of fat 
tissue x 10,000. The data on the graph is the result of the 
average of three rats. Both fat pads w~re assayed individually. 
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A column {2.5 x 50 cm) was packed with Dowex AG 50-X8 (sodium 
form, analytical grade) and equilibrated with 0.15 H ilaCl for 4 
hours. Following the saline equilibration, the resin was washed 
with 3 1 iters of a 0.15 N di basic sodium phosphate, solution until 
a pH of 6.6 was reached. 300 - 500 ml of pooled human serum was 
then passed through a column containing 175 ml of the resin, at a 
rate of 8 ml per minute. Once the serum had passed through the 
resin, the resin was vJashed vtith two column volumes of 0.15 ti iJaCl 
to remove contaminating substances. The IPC was then eluted with one 
column vol1me of 0.1 tl ammonium hydroxide. The pH of the eluate v1as 
monitored with a pH meter and kept at pH 7.0 + 0.5 VJith 2 tl H2S04 
s.olution. After dialysis against 0.15 N NaCl the eluate ·.;as freez.~­
dried, To test the freeze-dried fraction, it was redisscivE~ :~ a 
specified volume of buffer and dialyzed against Gey-Gey buffer for 
24 hours at 4°C with several buffer changes. The dialyzed ~re:ara­
tion was then tested with the rat diaphragm method to which a~ 
adipose tissue extract v.;as added (see 11Materialsand Methods 11 , page 56 
69). The result of this experiment, which was repeated sever3l ti~es, 
was negative, thus confirming the reports by Mead (75) and by Serso'1 
and Yalow (76) concerning inability to reproduce the rcsul ts re~~rted 
by Antoniades. There are a number of explanations for our failure to 
reproduce Antoniades 1 work. As early as 1932, Jemen and Evans (140) 
reported that insulin is destroyed rather rapidly in aqueous solutions 
71 
at pH values over 9.1. To elute the IPC, Antoniades used ammonium 
hydroxide solutions with pH values approaching 11. Du Vigneaud, in 
1941 (141), and Cavalli, in 1970 (142), confirmed the work of 
Jemen and Evan. They gave as a reason the hydrolysis of the amide 
bonds and the disruption of the cystine bond in the ,insulin molecule. 
Schultz et al. in 1962 (144) and Grannis in 1960 (143) reported that 
dilute acids may also denature the hormone by hydrolyzing the as-
paragine and glutamine residues. The use of 2 N H2so4 for neutral iza-
tion cre~tes locally elevated concentrations of hydrogen ion which 
may destroy the hormone. 
Kuzhetsova and Samsonav,· in 1969 (145), showed that strong 
basic, as well as acidic ion exchange resins may als~ denature in-
sulin. This finding convinced us that the methods used by Antoniades 
and coworkers· were too harsh, and probably.were responsible for the 
loss of insulin activity in our preparations. 
We turned, then, to the development of mi.Ider isolation tech-
niques. We tried three different cationic exchange resins, Sephadex 
·c-50, BioRad Rex 63, and Amber! ite ICR 50. BioRad Rex 63 has phos-
phate and Sephadex C-50 and Amberl ite have carboxyl residues as the 
active groups, instead of sulfate groups, as in Dowex AG 50-'X8. The 
reason for using thes~ resins was twofold. First, hydrolysis of 
insulin can be minimized due to its rather weak acidic groups and 
secondly ~lutions of the IPC requires milder eluants. The result of 
I 
Figure 5. - Elution profile when human serum was chromatographed 
on Sephadex p-50. Four peaks, absorbing at 280 nm were obtained 
when an (NH4)2co3 gradient ranging from 0.005 M + J.000 M pH 7.8 
. 
was used. The ~haded area over peak 4 represents insulin-1 ike 
activity expre~ed in ,µU as assayed with the rat diaphragm 
bioassay. 
. . 
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ILA DISTRIBUTION OF HUMAN SERUM OBTAINED WITH SEPHADEX C-50. 
TABLE XI 
ATE · Heparin (Biotin 
100 µg Protein 100 µg 
Pe;ak 
' 
0 0 . 
< 
Peak II 0 0 
~ 
Peak I I I ± ± 
Peak IV +++ +++ 
± Mbans traces. 
+++ Means between 200-300 µU of Insulin-like activity/ml serum. 
·++++ Means over 300 µU of Insulin-like activity/ml serum. 
10 µg 
.,.--., 
0 
± 
± 
++++ 
The table shows the qualitative distribution of insulin-like activity/ml 
of human serum. The qualitative data of ILA was obtained with the rat 
herni-diaphragrn bioassay. 6 
' . 
'· 
-...J 
w 
.., 
Resin Acidic 
groups 
~i 
TAB LE X 11 
COMPARATIVE TEST FOR ILA WITH DIFFERENT ION EXCHANGE RESINS. 
Insulin activity µU equivalent/ml serum 
Radioimmunoassay Diaphragm Assay 
Heparin Biotin IPC Heparin Biotin IPC 
+ S.E.M.* + S.E.M. + S.E.M. + S.E.M. + S.E.M.. + S.E.M • 
Sephadex C-50 carboxyl 115 ± 20 (3)t 22 ± 15 (3)t 22 ± 15 . 200 ± 55 (3)t 310 ± 35 (3)t 0 
Amberlite IRC carboxyl . 107 ± 30 (3) 20±11(3) 20 ± 11 175 ± 70 (3) 293 ± 47 (3) 0 
50 - 100 mesh 
Bio-Rad Rex 63 phosphate 89 ± 17 (3) 8 ±. 6 (3) 8 '± 6 117±30 (3) 217 ± 67 (3) 0 ....._. ~ 
Dowex AG 50-X8 sulfate 5 (3) 0 (3) 0 10 (3) l7 (3) 0 
* Standard error of the mean 
t Results were obtained from three different runs. 
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the isolation of IPC on Sephadex C-50 can be seen in Figure 5 and 
Table X. The procedure is outlined in the section devoted to 
11Materials and Methods'', page 51. All elution peaks were individually 
pooled and tested for insulin activity with the radioimmunoassay 
procedure as'well as with the rat diaphragm bioassay. Peak I, I I 
-J 
and I I I Figure 6 did not show any insulin-like activity. Using the 
radioimmunoassay and the rat diaphragm bioassay, the fourth peak 
showed ·considerable insulin-like activity, Figure 5 and Table X, 
when the protein of peak IV was preincubated for 30 minutes with 
100 µg/ml of heparin. (Explanation concerning heparin will follow, 
see page 110). When this material was/re(ncu~?ted with 10 µg/ml P 
of biotin it showed activity only with the rat diaphragm bioassay, 
but not with the radioimmunoassay. These results indicate that both 
heparin and biotin can activate the inactive IPC, but apparently by 
different mechanisms. The data comparing the ~esults from the 
different resins are summarized in Table XI I. 
Purification of the IPC by gel filtration. 
The insulin active fractions obtained from the Sephadex C-50 
were concentrated and desalted with an Amicon ultrafiltration appara-
tus. The salt free solution was then freeze-dried. From 1 liter 
of human serum an average of 2,000-3,ooo·mg of protein was obtained. 
One mg of this substance represents an average of 20-40 µU of in-
sulin equivalence. Further purification was achieved by gel filtra-
ti on on Sephadex G-200. An a 1 i quot of I PC from Sep.hadex C-50 was 
( 
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dissolved in Tris-NaCl buffer (0.1 N NaCl in 0.05 N Tris buffe~) pH 
7.4. The protein solution was then appl led to a Sephadex G-200 
column (2.5 x 100 cm) which had been equilibrated with the same 
buffer for 5 hours. The elution pattern is shown in Figure 6. 
It exhibits five peaks, absorbing in the region of 280 nm. To re-
solve peaks I I and I I I, IV and V, tubes #15 - 35, 36 - 42, 42 - 60, 
65 - 73 and 74 - 84 were individually pooled, concentrated and re-
chromatographed on the same column. The result is shown in Figure 
7. Each· elution peak was assayed for insulin-1 ike activity with 
the radioimmunoassay and the rat -intraperitoneal bio,ssay. The re-
sults can be seen in Tables XI 11 & XIV. This purification step 
revealed 2 distinct fractions of original peak IV (see Figure 5) 
which exhibit insulin activity. A·n exciting finding was the fact 
that peaks I I and I I I are both active with the in vivo bioassay 
. . ---
vJhereas only peak 111 showed activity, when tested" with the radio-
immunoassay. It is also interesting to note, that heparin as well 
as biotin with the bioassay ~vivo are not as effective as in the 
·.!!!.vitro bioassay. A possible explanation for this phenomenon may 
be that the intact animal may utilize the IPC throu~h its own heparin 
and biotin system. 
Electrophoretically, the two peaks cannot be dlstinguished very 
well, since both yield predominantly beta globulin bands when, the 
electrophoretic separation was carried out on cellulose acetate 
membranes (Beckman Microzone Apparatus). Figure 8 shows the elution 
. . 
~-
Figure 6. -LElution pattern of human serum insuJin protein 
complex, when chromatographed on Sephadex G-200 with Tris-NaCl 
. 
buffer 0.15 M pH 7.4. (Column: JOO x 2.5 cm). 
. i 
. . 
.~' 
Figure 7. - .Gel chromatography (G-200 Tris-NaCl buffer pH 7.4) 
pattern of the individual peaks obtained in figure 6 .. The 
hatched area represents five individual. peaks which were 
individually assayed for insulin-like activity. 
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TABLE XI 11 
.. 
.. -',,... 
RAD I 0 I MMU tJOAS SAY 
'-· µU Insulin Equivalence 
Peak Amount IPC + Heparin/0.1 mg IPC + Biotin/O.Olmg IPC 
mg • r + S.E.M. + S.E.M. + S.E.M. 
Ci 
10 0 (3) "' 0 0 
,- ~ - , ! I 
11 10 0 (3). 0 0 
10 103 + 17 (3) 33 !. 7 30 + 5 
- -
111 
IV 10 0 (3) 0 0 
v 10 0 (3) 5 0 0 
* three different runs 
TABLE XIV 
RAT INTRAPERITONEAL BIOASSAY 
µU lnsul in Equivalence 
Peak Amount IPC + Heparin/O. 1 mg I PC + Biotin/0.01 mg I PC 
mg + S.E.M. + S.E.M. + S.E.M. 
10 0 (3) "' 0 0 
11 10 270 !. 25 (3) 237 + 18 211 + 29 
- -
111 10 133 + 70 (J) 119 !. 29 112 + 33 
IV 10 0 (3) 0 0 
v 10 0 (3) 0 0 
;'\ three different 'runs 
~ 
Figure 8. - Elution profile of whole human serum on a Sephadex 
G-200 column (100 x 2.5 cm), eluted with Tris-NaCl 0.15 M pH 7.4. 
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pattern of whole h~man serum, when chromatographed on Sephadex · 
G-200, demonstrating the.absolute necessity of the cationic ex-
change isolation step. 
Determination of the Molecular Weights of Peak I l and Peak I I I. 
For the purpose of determining the molecular weights of peak 
11 and peak 11.1, the gel filtration technique was employed. As 
reference standards, proteins with known molecular weights were 
used. These were: 
Aldolase 
( 
MH 158,000 
Ovalbumin MW 45,000 .' 
Chymotrypsinogen MW 25,000 
Ribonuclease MW 13,700 
Only the center portion~ of the two peaks were taken and applied to 
a.Seehadex G-200.column. The protei~s were eluted with Tris-NaCl 
buffer at a p8 of 7.4.and a constant flow rate was maintained with 
. 
a peristaltic pump. The results of .this experiment are shown in 
Table XV and in Figure 9. From the elution column of ·peak I I and 
I I I, and subsequent calculations and comparison with the elution 
curve of the known protein peaks, the molecular weight of peak II 
was estimated to be 159,000 and that of peak I I I to be 95,000 -
98,000. Th.is finding showed that peak 11 was apparently the ILA-
compound isolated by Froesch and coworkers (155) which could not be 
suppressed by insulin antiserum. 
Since we had shown that hgparin enhances the insulin activity 
. 82 
MOLECULAR \iJEIGHT DE-TERMINATION OF INSULlt~ PROTEIN COMPLEX. 
Calculation 
Elution volume of column 2~5 x 100 
Knovm Proteins 
Dextran 
Aldolase 
Ovalbumin 
Chymotrypsinogen 
Ribonuclease 
Peak 11 
Peak 111 
159 ml 
209 ml 
CJ 
312 ml 
354 ml 
390 ml 
208 ml 
259 ml 
All elution values are the mean of 3 runs. 
K = Ve - Vo 
. l.o av Vt - Vo 
Ve = elution volume for protein .'1·, 
Vo = elution volume of Dextran 
Vt = total bed volume 
·,. 
83 
TABLE XV 
CALCULATION OF MOLECULAR WEIGHT OF ILA FRACTIONS WITH SEPHADEX G-200 
Calculations of Kav: 
Vt = 442 ml 
V = 159 ml 0 
Aldolase: 209 - 1)9 = 50 = 0.176 
-
442 - 159 283 
Ovalbumin: 312 - 159 = 153 = 0.541 
442 159 283 
Chymotrypsinogen: 354 159 195 0.689 = 283 = 442 - 159 
Ribonuclease: 390 - 159 231 = - = 0.816 442 - 159 283 
Peak I I : 208 159 49 = o. 171 = _, 
442 - 159 283 
Peak I I I ; 259 - 159 = · 100 = 0.353 
442 - 159 283 
Figure 9. - The graph represents standard curve for molecular 
weight determination with the gel filtration technique. The 
curve was obtained on a Sephadex G-200 column (100 x ~.5 cm) 
using four different proteins with known molecular weight. 
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of the IPC when assayed with the radioimmunoassay as well as with 
the rat diaphragm assay, we wanted to quantitate the effect or 
.. 
amount of IRI l !berated which is due to heparin. This quantitation 
was performed with the radio immunoassay. Table XVI and Figure 10 
show the results of the radioimmunoassay of IPC without any additions. 
Figure 11 and Table XVII show the results of the preincubation of 
IPC with 100 g/ml of heparin. One can easily detect a definite 
change in the slope. Figure 12 and Table XVI II show the results of 
the preincubation of IPC with tolbutamide (0.037 M), a hypoglycemic 
agent. Here also a marked increase in the slope is observed. To 
determine whether or not the effect of heparin and tolbutamide is 
an artifact, due to an alteration of the immunoreaction, a series 
of insulin standards were run in the presence and absence of he~arin 
and tolbutamide. Heparin showed no effect on the radioimmunoassay 
using crystalline bovine insulin. Feldman et al. .in 1973 (147) 
reported similar findings. Tolbutamide, on the other hand, showed 
an enhancement of the radio immunoassay with crystalline bovine in-
sulin. These results, then, demonstrate that while the activation 
of IPC by heparin is, in fact, a true activation, the effect of 
tolbutamide may be an artifact due to an interference of the immuno-
reaction between the insulin and the insulin antiserum, The.finding 
in this laboratory with tolbutamide shows that the earlier report on 
the same subject by Hasselblatt (148), namely that tolbutamide alters 
the radioimmunoassay in such a way that the antibody-antigen reaction 
86 
TAB LE XV I 
RADIO IMMUNOASSAY OF INSULIN PROTEIN COMPLEX 
NO ''ACTIVATOR" ARE ADDED. 
Test I PC CPM-:-S.E.M. Co/Cl 
l'JO. ;'~ mg 
5 5 5414.:. 85 1 • 139 
5 10 5140 .:. 31 1. 200 
5 20 4852 + 52 1.272 
5 30 4173.:. 90 .}. 479 
5 40 3877 .:. 40 1. 592 
5 50 3538 .:. 49 .1. 744 
5 0 6171 .:,113 1. 000 
i'\. Test was run three .ti mes. 
Figure 10. - The graph wai obtained when purified human insulin-
protein complex was assayed with the radioimmunoassay, and plotted 
according to the technique of Hales and Randle. The distinct 
slope indicates the presence of immuno-reactable insulin (IRI). 
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TAB LE XVI I 
RADIOIMMUNOASSAY OF INSULIN-PROTEIN COMPLEX. 
IPC WAS PREINCUBATED AT 33°C WITH lOO·µg OF HEPARIN FOR 30 MINUTES. 
Test IPC Heparin CPM + S.E.M. C0 /Cl 
No.~·~ mg µg 
5 5 100 4652 + 29 l .326 
5 . 10 100 4395 !. 22 1 .404 
5 20 100 4148 + 56 l.487 
5 30 100 3505 !. 44 l • 76 l 
5 40 100 3260 + 33 l.893 
5 50 100 2968· !. 31 2.079 
5 0 100 6171 + 113 1.000 
5 0 0 6170 + 101 l. 000 
~·~The test was run 3 times. 
TABLE XVIII 
RADIOIMMUNOASSAY OF INSULIN-PROTEIN COMPLEX. 
THE IPC WAiS PREINCUBATED AT 37°C WITH 100 mg OF TOLBUTAMIDE FOR 30 MINUTES. 
I 
Test IPC Tolbutamide CPM + S.E.M. Co/Cl 
No.-;', mg mg 
5 5 1.0 5359 ± 70 l • 15 l 
5 10 l.O 5150 ± 31 l • 198 
5 20 l.O .4932 ± 67 l • 25 l 
I 
94 5 30 l. 0 3926 ± l.572 
5 40 1.0 3753 ± 31 l. 644 
_, 
5 50 l.0 3205 ± 49 l.926 
5 0 l.O 6171 ± 79 1. 553 
5 0 0 3973 ± 101 1 .000 
·f: 
The test was run 3 t im"es. 
Figure 11. - A Randle and Hale plot (radioimmunoassay) of 
human insulin-protein complex when the IPC was preincubated for 
30 minutes at 37°C wi.th 100 µg of heparin prior to the radio-
immunoassay. 
Figure 12. - A Randle and Hale ~lot (ra~ioimmunoass~y) on 
human JPC which was preincubated with l mg of tolbutamide 
for 30 minutes at 37°C prior to the radioimmunoassay. 
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from !PC when assayed with the radioimmunoassay. The curve with the 
triangles represents !PC when preincubated with tolbutamide. The 
curve with the circles represents IPC with no additives and the 
curve with the squares represents IPC preincubated with heparin. 
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is inhibited, and therefore an apparent enhancement of the action of 
tolbutamide on IPC may very well be an artifact. 
The effect of IPC on the insulin radioimmunoassay. 
The possibility existed that, in the IPC which was isolated, 
there might be some substance which interfered with the radioimmuno-
assay. To assess the .likelihood of such a possibility, we carried 
out the following experiment. To a known amount of IPC, we added 
20, 50 and 100 µU of crystalline bovine insulin and then ass~yed the 
mixtures using the radioimmunoassay. The rationale behind this ex-
periment was the foHowing: if an interfering substance were pre-
sent in the IPC preparation it would interfere with the radioimmuno-
assay. The resulting increment in. insulin activity due to the added 
pure insulin over the endogenous IPC activity should not be stoichio-
metric. If we should obtain results. showing a stoichiometric .incre-
ment in insultn activity, precisely related to the amount oP pure 
insulin added, then we could, with confidence, say that in IPC there 
are no substances which interfere with the radioimmunoassay. Figure 
14 and Table XIX a, b, in fact, show a stoichiometric increment in 
insulin activity precisely related to the amount of insulin added. 
From these data, we conclude that the radioimmunoassay is not in-
terfered with by any substance in the IPC, and, therefore, the·in-
sul in activity exhibited by IPC, using the radioimmunoassay, is true 
immunologically active insulin. 
TAB LE Xi Xa 
RADIOIMMUNOASSAY - INTERFERENC.E STUDY 
OF IPC ON THE RADIOIMMUNOASSAY 
Test I nsu 1 in !PC CPM Co/Cl C /Cl ± S.E.M. 
No. µU mg 0 . 
20 .,,. 5319 1. 194 1.200 ± 0.035 
2 20 5230 1.215 
3 20 I - 5337 1. 191 
50 4162 1 .526 '1.617 ± 0.045 
2 50 3764 l .688 
3 50 3879 1.638 
100 3057 2.093 2.032 ± 0.032 
2 100 3211 1 .979 
3 100 3137 2.026 
30 4691 l. 354 1 . 4 3 5 ± 0 . 09 8 
2 30 4111 1.545 
3 30. 4517 l. 407 
18 5340 1 .190 1.225 ± 0.018 
2 18 5102 l. 245 
3 18 5117 1. 241 
12 5439 l. 168 l . 192 ± 0·.012 
2 12 5311 l . 196 
3 12 5239 l . 213 
· 1 6292 6355 ± 29 
2 6378 
3 6397 
92a 
TABLE XIXb 
• > 
RADIOIMMUNOASSAY - INTERFERENCE STUDY 
OF I Pc' ON THE RADIO IMMUNOASSAY 
Rat I nsu Ii n IPC CPM ± S.E.M. Co/Cl 
No. µU mg 
1-3 20 12 4388 ± 35 1 .448 
3-6 . 50 12 3318 ± 56 1 . 915 
6-9 100 12 2408 ± 27 2.039 
9-12 20 18 4211 ± 22 1.509 
12-15 50 18 3093 ± 31 2.054 
15-18, 100 18 2326 ± 26 2.731 
21-24 20 30 4024 ± 6Lt I .579 
24-27 50 30 2673 ± 15 2.377 
29-30 100 30 2062 ± 21 3.051 
. \ 
Figure 14. - This graph shows the result of the study of 
whet~er or not the isolated IPC will influence the radloimmunoassay. 
The solid triangle shows IPC activity when measured with the immuno-
assay. The open circle broke~ line shows the activity of crystalline 
bovine insulin. The open line with the open triangle represents 
the activity of crystalline insulin of 20 uU, 50 uU and 100 uU to 
which 12 mg of IPC was added. The open line with the open squares 
represent the activity of crystal] ine insulin to which 18 mg of 
!PC was added. The open circle solid 1 ine repre~ents crystalline 
insulin to which 30 mg of IPC was added. 
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Binding Studies of Insulin to Lysozyme. 
Since the IPC was isolated from a cation exchange resin, one can 
assume that the IPC;consists of insulin bound to a basic substance 
and that the complex is basic. Our experiments with heparin could 
be interpreted as a competition between heparin, an acidic glycos-
aminoglycan, and insulin, for the basic protein of the IPC. ·Heparin 
could preferentially· bind the basic protein of IPC, resulting in the 
liberation of free insulin, which then could be assayed by the radio-
immunoassay. 
Since, in human plasma, one of the most basic proteins is lyso-
zyme (pl, 10 - 11), we investigated the possibility that lysozyme 
might be the basic protein of the IPC. Determinations of lysozyme 
in plasma showed a concentration of 3.2 mg%, using hen egg white 
lysozyme as standards (Figure l~. Since human lysozyme is four 
times as active as hen egg white lysozyme, the concentration of ly-
sozyme in human plasma is, then, 0.8 mg% or 5.9 x 10-8 M. Freei 
circulating insulin in fasting humans is l x 10-9 M (page 14). 
Figure 16 shows that the peak of IPC from Sephadex C-50 also shows 
lysozyme activity. The question, then, arose of whether or not 
lysozyme binds insulin at physiological pH and salt concentrations. 
To answer this question, 1251 . l. -1nsu 1n ( 150 µU) was mixed with an 
excess of lysozyme. (5 mg, in O. 15 M NaCl - 0.01 M sodium phosphate 
(pH 7. 4) . The mixture was chromatographed on a Sephadex G-50 column 
Figure 15. - The graph shows a typical standard curve of lysozyme 
when assayed with the radial diffusion agar technique. 
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equ i 1 i brated and e 1 uted with the same buffer. Figure· 17 shows the 
elution pattern. The first peak, at the void volume, represents al-
b . h. h . h 125 1 . 1 . b. 1 . um1n w 1c was present 1n t e -1nsu 1n as a sta 1 1zer. The 
small amount of radioactivity is present in this peak. The second 
peak showed most of the radioactivity as well as lysozyme. This 
indicates that a complex between lysozyme and insulin was formed, 
since lysozyme alone would be retarded more and e.lute in the position 
of the third peak. 
We have shown that insulin bJnds to lysozyme in vitro and that, 
furthermore, during the isolation of IPC on Sephadex C-50, lysozyme 
activity appears in the PIG peak. The presence of lysozyme in the 
IPC peak can be the result of three possible phenomena, 1) lysozyme 
and insulin are both present in plasma as separate molecules, and 
d~ring the isolation procedure, lys6zyme binds to the Sephadex and 
then insulin binds to lysozyme, resulting in the formation of a 
lysozyme-insulin complex; 2) lysozyme and insulin in plasma form a 
.complex and lysozyme is the basic protein of the IPC; and 3) lyso-
zyme and IPC elute from Sephadex C-50 at the same place because of 
similar charge characteristics. 
To determine whether or not the lysozyme and insulin form a 
complex on the column during the isolation procedure, a Sephadex 
c-50 column was loaded with lysozyme. 125 1-insulin was, then, placed 
on the column and eluted with O. 15 M NaCl. Figure 18 shows that the 
Figure 16, - This figure shows the assay for lysozyme of peak 4 
obtained with human serum when chromatographed with Sephadex 
C-50. Tubes 100~122 which showed insulin-like activity, also 
revealed high concentrations of lysozyme as can be seen on the 
lysis of the attached photography strip. 
: ! 
"" A.&.tAt&OW Nl,fteNI 
• 
-\..., o•• A.LleN•a"" 
97 
0 
• 
• 
• 
• z 
: : .. 
'E 
f II 
• .. 
I• 
;) 
.. 
: 
'! 
• 
j\ 
T 
)) 
J 
, . 
• _,,, ! 
. . ......_ .. \ 
\ 
.,! 1i 
~t l) 
"· I 
0 >) 
( 
Q \) 
1'1 
0 
98 
radioactivity was eluted with NaCl and recovered quantitatively. 
No lysozyme was eluted indicating that a lysozyme-insul in complex 
was not formed on t~e column. 
To investigate whether or not lysozyme is the basic substance 
which binds insulin in plasma, resulting in the formation of IPC, 
we ran a radioimmunoassay on crystal line insulin in the presence 
' of various concentrations of lysozyme. The rationale of this ex-
periment is as follows: the IPC we isolated shows very little 
activity when assayed by radioimmunoassay, unless it is first ac-
tivated by heparin. If lysozyme added to insulin (resulting in the 
formation of an insul in-lysozyme complex) would decrease the amount 
of insulin activity assayed by the radioimmunoassay, we could con-
elude that lysozyme may be a part of the IPC. If no decrease were 
observed, it ~ould support the idea that lysozyme and IPC co-elute 
only by coincidence. 
Figure 19 - 22 and Table XX show that lysozyme does not affect 
the radioimmunoassay in any way. These data show that lysozyme is 
not part of the IPC and that their cg-elution is coincidental and 
due only to their similar charge characteristics. 
Comparative Study to Isolate IPC from Different Animals. 
The attempt to isolate the insulin-protein complex from serum 
of dogs, horses, calves and chicken was unsuccessful. In all cases 
the isolation procedure outlined in 11Materials and Methods 11 was 
Figure 17. - El~tion profile of 125 1~insulin-lysozyme complex 
on. Sephadex G-50. The broken curve represents radioactivity; 
the solid line the protein peaks. For description of experiment 
see text. 
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TABLE XX 
INFLUENCE OF LYSOZYME ON THE RADIOIMMUNOASSAY. 
Insulin Lysozyme CPM + S.E.M.~<: Co/Cl 
µU mg% 
10 9495 + 73 1 .032 
20 8975 + 43 1. 091 
50 7697 + 90 1.273 
100 6582 + 97 1. 488 
200 5852+118 1.674 
10 1 • 2 9060 + 68 1.081 
20 1.2 8556 + 95 l. 146 
50 1.2 8301 + 94 1. 180 
100 1.2 . 7640 +. 134 l. 27.5 
200 1.2 5406 + 122 l.812 
10 4.0 8314 + 139 1 • 178 
20 4·. 0 8518 + 129 l. 150 
50 4.0 7239 + 86 1.353 
100 4.0 6569 + 90 1. 491 
200 .. 4 .o 5818 + 78 l. 689 
l 0 8.o 9436 + 138 1. 038 
20 8.o 9408 + 186 l. 037 
50 8.o 8295 + 106 1 • 181 
l 00 8.0 6534 + 80 l. ~99 
200 8.0 5572 + 93 1. 758 
0 1.2 9825 + 129 0.998 
0 4.0 9813 + 130 0.999 
0 8.o 9808 + 142 1. 000 
0 0 9810 !. 137 l .000 
~Values were obtained from five duplicates. 
figure 19. - Radio~mmunoassay. (Randle and Hales plot) of 
crystalline bovine insulin. 
Figure 20. - Radioimmunoassay (Randle and Hales plot) of 
crystalline bovine insulin'when a solution of 1.2 mg% of 
lysozyme was added. 
', .. 
Figure 21. - Radioimmunoassay (Randle and Hales pl?t) of ·r 
crystalline bovine insulin when a solution of 4.0 mg% of 
lysozyme was added. 
Figure 22. - Radioimmunoassay (Randle an~ Hales plot) of 
cry5talline bovine insulin when a solution of 8.0 mg% of 
lysozyme was added. 
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applied. Among all animals, the dog was the only animal which showed 
traces of IPC, when measured with the radioimmunoassay procedure and 
in the presence of heparin. This ex per i men t would 1 ead one to be-
lieve that the insulin-protein complex may be unique to humans. Tests 
on other animals would give.a more definite answer. 
TABLE XXI 
Animals I PC/m 1 serum 
Heparin Biotin 
Human 2 I !_ 9* 
Dog 19 + 3 
'i) 5 + 2 
Horse 0 0 
Calf 0 0 
Chicken 0 0 
'"values were obtained with the radioimmunoassay 
r 
'> 
TABLE XXI 
COMPARATIVE STUDY bF IPC ON blFFERENT ASSAYS 
-? 
Insulin equivalence/ml plasma 
1. Radioimmunoassay 
2. Rat Diaphragm Bioassal 
Test 
Nos. 
7 
9 
.. 
3. Rat lntraperitoneal Bioassay 6 
* Standard error of the mean. 
I PC 
+ S.E.M.;'c 
20 + 10 
15 + 11 
260 + 50 
) 
I PC/Heparin I PC/Biotin 
+ S.E.M. + S.E.M. 
-
/ 
115::._12 21 + 9 
203 + 30 320 ::.. 40 
252 + 28 374 ::.. 63 
0 
+:-
Figure 23. - A graphic interpretation of Table XX (Bl = IPC) 
on each of the three schemes. The first vertical grouping 
represents the amount of I PC/ml serum -when assayed without 
an ''activator'' with the radioimmunoassay, rat hemi-diaphragm 
bioassay and with the~ vivo rat intraperitoneal bioassay. 
The second vertical grouping represents, the IPC values of IPC 
when heparin was used as an "activator". The third vertical 
grouping represents biotin when used as an "activator". The 
fourth vertical grouping represents the rat diaphragm and rat 
,1 
intraperitoneal bioassay when biotin was blocked by avidin. 
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CHAPTER IV 
1 DISCUSSION 
One of the ~ost intriguing and yet frustrating chapters in 
diabetes research involves the study of insul in-1 ike activity in 
human plasma and serum~ The term intriguing seems ~o describe the 
results thus far obtained from various investigators. On the other 
hand, this field is an extremely frustrating one in that despite 
') 
what appears to be well understood and accepted operational defini-
tions and comparable procedures and techniques the results are often 
not uniform and frequently contradictory. 
Since the mid 1950s the literature is replete with reports by 
various groups all over the world, that there may exist substances 
which exhibit insulin-like activity. The term insulin-like activity 
refers to as yet uncharacterized substances which seem to be able 
to assist glucose utilization by the muscle and fat cells. However, 
these substances seem to lack characteristics which are unique to 
the hormone insulin, namely controlling e~zyme mechanisms in car-
bohydrate, protein and lipid metabolism (see lntrod~ction, page 18). 
These compounds do· not have the ab i 1 i ty to induce prate in synthesis . 
(91) • 
106 
107 . 
Insulin-like activity has been subdivided into two categories: 
a. insulin-protein complexes, and b. compounds which have nothing 
in common with insulin, as far as molecular structure is concerned 
(155). As described in the 11 lntroduc.tion 11 and 11Results 11 our labora-
tory was interested in reinvestigating the reports which came from 
the laboratory of _Antoniades and coworkers (58) and Shaw et al. (70) 
that insulin circulates in blood in a free and bound forms. This 
theory has been rejected by Berson et al. (76) and Meade et al. (75) 
who have·not been able to demonstrate 11bound insul in 11 • In 1964 
Froesch (94), in Switzerland, wa~ able t~ isolate an~ later (155) 
characterize a compound which· exhibits insulin-like activity. Since 
this finding the hypothesis that insulin could be bound to a basic 
protein has been abandoned. In. fact, Poffenbarger and his colleagues 
(84) believe that 11 bound 11 insulin, as described by Antoniades, and 
the compound with insulin-like activity elucidated' by Froesch are 
one and the same substance. Froesch agrees with this group to some 
extent in that he writes: 11 Purified smal 1 molecular ·weight non-
·suppressible ILA (6,000 to 10,000) was chromatographed on Dowex 
and recovered in the alkaline eluate, thus fulfilli~g the criteria 
of 11 bound insulin 11 • We believe that this statement is rather con-
fusing, because insulin as a dimer (Zn-insulin) has a MW of 12,000 
in the pH range of 7.8 - 8.2 as reported by Boyle and Hexmer '(149) 
,• 
and above'pH 10 insulin exists as a monomer of a MW of 6,000 as re-
ported by Marcker (150) •. It seems reasonabl_e to assume that an insulin-
p'rotein complex has·to have a M\~ greater than the MW of insulin itself. 
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Furthermore, our hypothesis is that this complex in all probability 
I 
will not exhibit insulin activity, unless physical or.chemical methods 
are applied to dissociate the complex, thus releasing active insulin. 
When the procedure of Antoniades and coworkers was applied to 
isolate 11 bound 11 insulin, we were not able to reproduce their results, 
and thus were faced with two possible alternatives; either (a) 
Antoniades had fallen victim to an artifact of the experimental 
procedure he employed, or (b) his separation procedures were too 
harsh. For reasons already described under 11Results 11 namely, that 
the choice of a cation exchange resin, with its very acidic sulfate 
groups, and the elution method which creates a pH over l 1, coupled 
with the harsh subsequent neutralization method, might have destroyed 
whatever insulin-protein complex was present in human plasma 'or 
serum, we,decided to reinvestigate the possible presence of a 
11 boun<l 11 insulin using much milder conditions. For this purpose we 
used Sephadex C-50, Amberl ite IRC-50 and BioRad Rex 63, since all 
three resins have weaker exchange residues than Dowex and, therefore, 
minimize the possibility of hydrolysis.of insulin through the acidic 
groups or highly alkaline elutants, since a lower pH is required to 
elute any insulin-protein complex bound to these resins. 
f 
The results which we obtained with these resins are shown in 
Table XII and the graphical pattern of the elution with ammonium 
carbonate in Figure 5. These·results strongly suggest, that when 
the IPC compound was tested for insulin activity with the radioimmuno-
assay and the hemidiaphragm bioassay, it exhibited ~ctivity, but 
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only after the IPC had been preincubated with 0. 1 mg/ml of heparin 
and 0.01 mg/ml of biotin. These compounds are designated as 
11activators 11 • In 1968 Gjedde (151) reported that insulin was bound 
to serum globulins and later Cantrell et al. (152) reported the 
binding of insulin to immunoglobulins. These reports suggested 
to us that indeed i~sulin binds to other serum proteins. 
Table XVI demonstrates that with the radioimniunoassay small 
amounts of immunoreaciive insulin were picked up without the addition 
of 11activafors 11 • The validity of this finding was confirmed with 
two experiments. If the values of 20 µU/ml of serum represent 
immunoreactive insulin, then we.should be able to obtain a typical 
Randle and Hales plot, if increasing amounts of IPC are assayed 
with the radioimmunoassay procedure. The results of th1s experi-
ment are listed.in Table XVI indicating the presence of insulin in 
the protein preparation. The question of whether or' not the slope 
was the' result of an alteration of the radioimmunoassay by some 
compo~nd in the IPC preparation was answered in the secbnd experi-
ment. Constant amounts of purified insulin were added to increasing 
amounts of 1ec and then ~~sayed. · Figure 14, and Table XIXa and b 
showed almost an exact additive effe.ct in the change of the slope 
' 
caused by exogenous insulin. 
Havihg performed these experiments, the question arose as to 
whether we were dealing with an insulin-protein complex which 
·, 
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dissociates to some extent in~~ free insulin and basic protein, or 
whether the insulin determined with the radioimmunoassay was an 
artifact due to trapped insulin in the resin. This possibility 
seemed unlikely since for these studies peak I I I from Sephadex G-200 
was used exclusively. To eliminate the possibility of an artifact, 
the IPC prepar~tion was incubated with heparin (0.1 mg/ml). Heparin 
as well as insulin a~e both anionic substances, but since heparin 
is much more anionic than insulin, one.can expect that heparin will 
bind preferentially to the basic component of IPC, thus releasing 
free insulin. The results of this experiment are shown in Table XVI I 
and Figure 11. Under these conditions, the radioimmunoassay picked 
up five times'as much insulin, demonstrating that heparin does, in 
fact, release insulin and that insulin is bound to a basic protein 
and that furthermore the 11bound 11 insulin is not immunoreactive. 
This experiment did not give any conclusive proof as to the nature 
of the insulin-protein complex, but it shows that circulating insulin 
is complexed in part to some basic protein. Heparin also enhanced 
,the insulin activity of the IPC. using the .rat hemidiaphragm bioassay. 
In this b.ioassay the increased activity was even more pronounced, 
approximately 500 per cent enhancement of activity being obtained. 
I . 
In 1963, Hasselblatt (148) and in 1970, Przyby·la (146) postulated 
an increase of ins.ulin-like activity, when they used the hypoglycemic 
drug tolbutamide. We therefore used this drug to strengthen our 
case. As seen in Figure 12, a definite increase in the slope was 
~. 
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achieved in comparjson with IPC alone. However, this result may have 
proved to be an artifact. In fact, when tolbutamide was run with 
insulin standards the values were distorted, suggesting that the 
effect of tolbutamide resulted from an alteration of the insulin-
antibody reaction and had no effect on the IPC. ,Similar studies 
with heparin showe~ that it has no influence on the immunoreaction 
and that its effect was the result of the liberation of insulin from 
the IPC. This findrng was confirmed by Feldman in 1973 (147). 
The 'finding of Coggeshall in 1968 (153) that biotin plays a 
role in carbohydrate metabolism other than co 2 fixation led us to 
test biotin on the isolated IPC compound. Biotin in physiological 
concentration (0.01 mg/ml) was incubated for 30 minutes, as was 
heparin, with a specific amount ·of 0IPC. The preparation was then 
assayed for insulin activity with the radioimmunoassay and the rat 
hemidiaphragm .bioassay. The result.s of this experiment were very 
surprising indeed. The immunoassay showed absolutely no activity; 
howe.ver, the diaphragm responded significantly. The insulin activity 
~btained with biotin with the bioass~y was severely decreased when 
avid in, an .inhibitor for biotiri, was used, 
Since biotin alone failed to show any insulin activity using 
' 
the rat hemidiaphragm bioassay, in collaboration with Crolla (156) 
1n our laboratory, we performed deuterium exchange and circular 
dichroism ~tudies on the IPC compound, with the addition of bi6tin. 
We clearly showed conformational changes of the IPC by both methods. 
T~is finding suggested to us that through a change iri the 3-dimensional 
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structure of the IPC compound, insulin regains its biological activ-
ity. These results also suggested that IPC may not have to be dis-
sociated to obtain insulin activity. These results led us to per-
form an in vivo experiment {intraperitoneal bioassay) to determine 
-- . 
whether or not the IPC is involved in the transport of glucose 
across the cell membrane of muscle. The results of these experiments, 
summarized in Table XX, show that the IPC can be activated by the 
intact animal and that the addition of biotin and heparin did not 
·.result in any large augmentation of activity, indicating perhaps 
that the conplexed insulin is a normal phenomenon and not the result 
of pathological conditions in wl1ich the animal or human is deprived 
of biologically active insulin. The next question we investigated 
1:1as v1~1ether IPC is a unique feature of humans or it is also present 
in other animals. Thus, vie attempted to isolate the IPC from sera 
of calves, horses, dogs, and chickens. 1.Je \·1ere not ab·le to demonstrate 
any appreciable amounts in the sera of these animals. 
In summary, ;-1e have demonstrated that with mild isolation methods 
an insulin-protein complex can be isolated from human serum v1hich is 
inactive v1hen assayed with an~ vitro insulin assay and that the 
complex can be activated by heparin and biotin. These two substances, 
however, activate the IPC through different mechanisms. Heparin binds 
to the basic component of the iPC liberating free insulin, whereas 
biotin causes a change in the 3-dimensional structure of IPC resulting 
in the IPC acting as insulin itself. Biotin somehow exposes the in-
sulin moiety of the IPC so that it becomes biologically active but 
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immunologically inactive. We also disproved earlier reports that 
tolbutamide plays a role in activating the IPC compound. Further-
more, we showed that pos~ibly only in human serum or plasma, is 
insulin carried and made inactive by a basic protein. 
As shown in the 11 Results 11 , five peaks were obtained when IPC 
was chromatographed on Sephadex G-200. lnsul in-1 ike activity was 
detected only in peak I I and I I I. Molecular weight estimation 
with gel filtration revealed ttW of 158,000 and 102,000 for peak II 
·and I I I respectively. Both peaks, when electrophoresed on cellu-
lose acetate, showed strong bands in the beta globulin fraction; 
both peaks were devoid of albumin and gamma globulin bands. Since 
peak I I did not show any insulin activity when measured with the 
radio immunoassay, we believe that this protein fraction represents 
the ILA compound, which has been isolated and characterized by 
Froesch and coworkers (94). Peak I I I, however, showed activity 
~1hen it 1-1as preincubated v1ith heparin and assayed v1ith the radio-
immunoassay. This may confirm Frocsch's observations that in plasma 
there exists a high molecuL:ir \·<eight substance (!LA) that exhibits 
insulin-I ike activity; furthermore it demonstrates the presence in 
human plasma of a bound form of insulin (IPC). 
We also investigated the possibility that lysozyme could be 
the basic protein which binds insulin in plasma to form the inactive 
IPC. However, we were unable to show that lysozyme is part of the 
IPC, even though insulin and lysozyme form complexes in vitro (159). 
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Whether the comp 1 exed fo_rm of i nsu 1 in is a norma 1. mechanism 
for insulin preservation or is a biological deactivatlon of phys-
iologrcal active ins.Lil in is unknown. Antoniades 1 report (69) that 
bound insulin seems to increase in some diabetic patients points 
to the latter possibility; however, this observation has not been 
.confirmed~ The question of why bound insulin has not been con-
sistently demonstrated in plasma remains unanswered. One explana-
tion could be that biotin and heparin, in the concentration used 
in our experiments, do not represent the concentration which the 
cells require to activate the insulin-protein complex. \4hat is 
the function of IPC7 One can only speculate. It could be a sort 
of 11delayed 11 mechanism of insulin action - a sort of built in 
buffertng system. Gerritzen has described (154) the use of Jelaying 
~-insulin action using insulin derivatives. The human body may have 
adopted such a delaying system in the form of an insulin-protein 
complex, long before synthesized insulin derivatives were used. 
CHAPTER V 
SUMMARY AND CONCLUSION 
In 1958, Antaniades (S8) described the presence of an insulin-
protein complex (IPC) in human serum. In the intervening years, 
a number of investigators have tried to isolate the IPC using 
Antoniades 1 methods, but wrthout success. Many investigators, on 
tbe basis of the work of Froesch,'have thought that Antoniades 
had actually isolated a high molecular weight substance with in-
sulin activity, as 1 in the work by Froesch. 
-In this investigation, using milder procedures, we have been 
able to isolate, from human serum, an IPC, with a MW of 100,000, 
which exhibits almost no insulin a~tivity with in vitro assay 
- . 
methods, such as the rat hemi-diaphragm bioassay or the radio-
immunoassay. However, the complex shows insulin activity when 
assayed with .!..!!. ~ assays.,_ such as the i ntraper i tonea 1 bi oassay. 
The !PC can be activated in vitro by incubation with heparin and 
biotin, but possibly not with Tolbutamide, contrary to what has 
been reported in the literature (148). The 11activated 11 IPC ex-
hibits insulin activity with ~·vitro bioassays. The mode of 
activation of the IPC by heparin is apparently due to the dissociation 
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of insulin from the complex, .whereas the activation by biotin appears 
to be due to a conformational change in the 3-dimensional structure 
of complexed insulin: 
Since lysozyme forms complexes with insulin in vitro, we thought 
that lysozyme may have been the basic protein of the IPC. However, 
we demonstrated that lysozyme is not part of the IPC. We also 
attempted to isolate the IPC from sera of calves, horses, dogs and 
chickens. In none of these sera were we able to show the presence 
of IPC. Thi.s would seem to indicate that an IPC may be characteristic: 
of humans alone. 
Speculations as to the function of IPC are difficult at the 
present, because it is not ·known whether IPC fluctuates under con-
ditions· of aberrant glucose metabolism. It may be a form of insulin 
r~which. is activated under physiological stress or it may be a mechanism 
to inactiv~te and conserve insulin. lf speculationscare difficult, 
we can say with confidence that the argument as to the existence 
or non-existence of an lPC in normal human serum can be put to rest. 
We have definetly proven that it.exists. 
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